Amcor plc 10-Q for FY2021 Q1
Amcor plc (AMCR)
10-Q
2021-05-06
For: 2021-03-31
View Original
Added on
April 10, 2026
About this 10-Q
Amcor plc filed this 10-Q on May 6, 2021, covering the quarter ended March 31, 2021 (FY2021 Q1).
Headline figures
Quarter ended March 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $3.21B
- up 2.1% from $3.14B a year earlier
- Net income
- $267M
- up 47.5% from net income of $181M a year earlier
- Diluted EPS
- $0.17
- up 51.8% from $0.11 a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
For the Quarterly Period Ended March 31, 2021
OR
For the transition period from __________ to __________
Commission File Number 001-38932
(Exact name of Registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||
(Address of principal executive offices)
Registrant’s telephone number, including area code: +44 117 9753200
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
1
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):
| ☒ | Emerging Growth Company | ||||||||||
| Non-Accelerated Filer | ☐ | Smaller Reporting Company | |||||||||
| Accelerated Filer | ☐ | ||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of May 4, 2021, the registrant had 1,541,792,948 ordinary shares, $0.01 par value, outstanding.
2
Amcor plc
Quarterly Report on Form 10-Q
Table of Contents
3
Cautionary Statement Regarding Forward-Looking Statements
Unless otherwise indicated, references to "Amcor," the "Company," "we," "our," and "us" in this Quarterly Report on Form 10-Q refer to Amcor plc and its consolidated subsidiaries.
This Quarterly Report on Form 10-Q contains certain statements that are "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identified with words like "believe," "expect," "target," "project," "may," "could," "would," "approximately," "possible," "will," "should," "intend," "plan," "anticipate," "estimate," "potential," "outlook," or "continue," the negative of these words, other terms of similar meaning or the use of future dates. Such statements are based on the current expectations of the management of Amcor and are qualified by the inherent risks and uncertainties surrounding future expectations generally. Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties. None of Amcor or any of its respective directors, executive officers or advisors, provide any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements will actually occur. Risks and uncertainties that could cause actual results to differ from expectations include, but are not limited to:
•The continued financial and operational impacts of the 2019 Novel Coronavirus ("COVID-19") pandemic on Amcor and its customers, suppliers, employees and the geographic markets in which it and its customers operate;
•changes in consumer demand patterns and customer requirements in numerous industries;
•the loss of key customers, a reduction in their production requirements or consolidation among key customers;
•significant competition in the industries and regions in which we operate;
•the failure to successfully integrate acquisitions in the expected time frame;
•the inability to expand our current business effectively through either organic growth, including by product innovation, or acquisitions;
•challenges to or the loss of our intellectual property rights;
•challenging current and future global economic conditions;
•impacts of operating internationally;
•price fluctuations or shortages in the availability of raw materials, energy and other inputs, which could adversely affect our business;
•production, supply and other commercial risks, including counterparty credit risks, which may be exacerbated in times of economic downturn;
•a failure in our information technology systems;
•an inability to attract and retain key personnel;
•costs and liabilities related to current and future environmental and health and safety laws and regulations;
•labor disputes;
•the possibility that the phase out of the London Interbank Offered Rate ("LIBOR") causes our interest expense to increase;
•foreign exchange rate risk;
•an increase in interest rates;
•a downgrade in our credit rating that could increase our borrowing costs and negatively affect our financial condition and results of operations;
•a failure to hedge effectively against adverse fluctuations in interest rates and foreign exchange rates;
•a significant write-down of goodwill and/or other intangible assets;
•our need to maintain an effective system of internal control over financial reporting in the future;
•an inability of our insurance policies, including our use of a captive insurance company, to provide adequate protection against all of the risks we face;
•litigation or regulatory developments;
•changing government regulations in environmental, health, and safety matters; and
•our ability to develop and successfully introduce new products and to develop, acquire and retain intellectual property rights.
These risks and uncertainties are supplemented by those identified from time to time in our filings with the Securities and Exchange Commission, including without limitation, those described under Part I, "Item 1A - Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended June 30, 2020. You can obtain copies of Amcor’s filings with the SEC for free at the SEC’s website (www.sec.gov). Forward-looking statements included herein are made only as of the date hereof and Amcor does not undertake any obligation to update any forward-looking statements, or any other information in this communication, as a result of new information, future developments or otherwise, or to correct any inaccuracies or omissions in them which become apparent, except as expressly required by law. All forward-looking statements in this communication are qualified in their entirety by this cautionary statement.
4
Part I - Financial Information
Item 1. Financial Statements
Amcor plc and Subsidiaries
Condensed Consolidated Statements of Income
(Unaudited)
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||||||
| ($ in millions, except per share data) | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||
| Net sales | $ | $ | $ | $ | ||||||||||||||||||||||
| Cost of sales | ( | ( | ( | ( | ||||||||||||||||||||||
| Gross profit | ||||||||||||||||||||||||||
| Operating expenses: | ||||||||||||||||||||||||||
| Selling, general and administrative expenses | ( | ( | ( | ( | ||||||||||||||||||||||
| Research and development expenses | ( | ( | ( | ( | ||||||||||||||||||||||
| Restructuring and related expenses, net | ( | ( | ( | |||||||||||||||||||||||
| Other income, net | ||||||||||||||||||||||||||
| Operating income | ||||||||||||||||||||||||||
| Interest income | ||||||||||||||||||||||||||
| Interest expense | ( | ( | ( | ( | ||||||||||||||||||||||
| Other non-operating income, net | ||||||||||||||||||||||||||
| Income from continuing operations before income taxes and equity in income of affiliated companies | ||||||||||||||||||||||||||
| Income tax expense | ( | ( | ( | ( | ||||||||||||||||||||||
| Equity in income of affiliated companies, net of tax | ||||||||||||||||||||||||||
| Income from continuing operations | ||||||||||||||||||||||||||
| Loss from discontinued operations, net of tax | ( | |||||||||||||||||||||||||
| Net income | $ | $ | $ | $ | ||||||||||||||||||||||
| Net income attributable to non-controlling interests | ( | ( | ( | ( | ||||||||||||||||||||||
| Net income attributable to Amcor plc | $ | $ | $ | $ | ||||||||||||||||||||||
| Basic earnings per share: | ||||||||||||||||||||||||||
| Income from continuing operations | $ | $ | $ | $ | ||||||||||||||||||||||
| Loss from discontinued operations | ( | |||||||||||||||||||||||||
| Net income | $ | $ | $ | $ | ||||||||||||||||||||||
| Diluted earnings per share: | ||||||||||||||||||||||||||
| Income from continuing operations | $ | $ | $ | $ | ||||||||||||||||||||||
| Loss from discontinued operations | ( | |||||||||||||||||||||||||
| Net income | $ | $ | $ | $ | ||||||||||||||||||||||
Note: Per share amounts may not add due to rounding. See accompanying notes to condensed consolidated financial statements.
5
Amcor plc and Subsidiaries
Condensed Consolidated Statements of Comprehensive Income
(Unaudited)
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||||||
| ($ in millions) | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||
| Net income | $ | $ | $ | $ | ||||||||||||||||||||||
| Other comprehensive income (loss): | ||||||||||||||||||||||||||
| Net gains (losses) on cash flow hedges, net of tax (a) | ( | ( | ||||||||||||||||||||||||
Foreign currency translation adjustments, net of tax (b) | ( | ( | ( | |||||||||||||||||||||||
Net investment hedge of foreign operations, net of tax (c) | ( | ( | ||||||||||||||||||||||||
Pension, net of tax (d) | ||||||||||||||||||||||||||
| Other comprehensive income (loss) | ( | ( | ( | |||||||||||||||||||||||
| Total comprehensive income (loss) | ( | |||||||||||||||||||||||||
| Comprehensive income attributable to non-controlling interest | ( | ( | ( | ( | ||||||||||||||||||||||
| Comprehensive income (loss) attributable to Amcor plc | $ | $ | ( | $ | $ | |||||||||||||||||||||
| (a) Tax benefit (expense) related to cash flow hedges | $ | ( | $ | $ | ( | $ | ||||||||||||||||||||
| (b) Tax benefit (expense) related to foreign currency translation adjustments | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||
| (c) Tax benefit related to net investment hedge of foreign operations | $ | $ | $ | $ | ||||||||||||||||||||||
| (d) Tax benefit related to pension adjustments | $ | $ | $ | $ | ||||||||||||||||||||||
See accompanying notes to condensed consolidated financial statements.
6
Amcor plc and Subsidiaries
Condensed Consolidated Balance Sheets
(Unaudited)
| ($ in millions except share and per share data) | March 31, 2021 | June 30, 2020 | ||||||||||||
| Assets | ||||||||||||||
| Current assets: | ||||||||||||||
| Cash and cash equivalents | $ | $ | ||||||||||||
| Trade receivables, net | ||||||||||||||
| Inventories, net | ||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||
| Total current assets | ||||||||||||||
| Non-current assets: | ||||||||||||||
| Investments in affiliated companies | ||||||||||||||
| Property, plant and equipment, net | ||||||||||||||
| Operating lease assets | ||||||||||||||
| Deferred tax assets | ||||||||||||||
| Other intangible assets, net | ||||||||||||||
| Goodwill | ||||||||||||||
| Employee benefit assets | ||||||||||||||
| Other non-current assets | ||||||||||||||
| Total non-current assets | ||||||||||||||
| Total assets | $ | $ | ||||||||||||
| Liabilities | ||||||||||||||
| Current liabilities: | ||||||||||||||
| Current portion of long-term debt | $ | $ | ||||||||||||
| Short-term debt | ||||||||||||||
| Trade payables | ||||||||||||||
| Accrued employee costs | ||||||||||||||
| Other current liabilities | ||||||||||||||
| Total current liabilities | ||||||||||||||
| Non-current liabilities: | ||||||||||||||
| Long-term debt, less current portion | ||||||||||||||
| Operating lease liabilities | ||||||||||||||
| Deferred tax liabilities | ||||||||||||||
| Employee benefit obligations | ||||||||||||||
| Other non-current liabilities | ||||||||||||||
| Total non-current liabilities | ||||||||||||||
| Total liabilities | ||||||||||||||
Commitments and contingencies (See Note 16) | ||||||||||||||
| Shareholders' Equity | ||||||||||||||
| Amcor plc shareholders’ equity: | ||||||||||||||
Ordinary shares ($ | ||||||||||||||
Authorized ( | ||||||||||||||
Issued ( | ||||||||||||||
| Additional paid-in capital | ||||||||||||||
| Retained earnings | ||||||||||||||
| Accumulated other comprehensive loss | ( | ( | ||||||||||||
Treasury shares ( | ( | ( | ||||||||||||
| Total Amcor plc shareholders' equity | ||||||||||||||
| Non-controlling interest | ||||||||||||||
| Total shareholders' equity | ||||||||||||||
| Total liabilities and shareholders' equity | $ | $ | ||||||||||||
See accompanying notes to condensed consolidated financial statements.
7
Amcor plc and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(Unaudited)
| Nine Months Ended March 31, | ||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||
| Cash flows from operating activities: | ||||||||||||||
| Net income | $ | $ | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||||
| Depreciation, amortization and impairment | ||||||||||||||
| Net periodic benefit cost | ||||||||||||||
| Amortization of debt discount and deferred financing costs | ||||||||||||||
| Net gain on disposal of property, plant and equipment | ( | ( | ||||||||||||
| Net gain on disposal of businesses | ( | |||||||||||||
| Equity in income of affiliated companies | ( | ( | ||||||||||||
| Net foreign exchange loss | ||||||||||||||
| Share-based compensation | ||||||||||||||
| Other, net | ( | |||||||||||||
| Loss from hyperinflationary accounting for Argentine subsidiaries | ||||||||||||||
| Deferred income taxes, net | ( | ( | ||||||||||||
| Dividends received from affiliated companies | ||||||||||||||
| Changes in operating assets and liabilities, excluding effect of acquisitions, divestitures, and currency | ( | ( | ||||||||||||
| Net cash provided by operating activities | ||||||||||||||
| Cash flows from investing activities: | ||||||||||||||
| Purchase of property, plant and equipment and other intangible assets | ( | ( | ||||||||||||
| Proceeds from divestitures | ||||||||||||||
| Proceeds from sales of property, plant and equipment and other intangible assets | ||||||||||||||
| Net cash (used in) provided by investing activities | ( | |||||||||||||
| Cash flows from financing activities: | ||||||||||||||
| Proceeds from issuance of shares | ||||||||||||||
| Purchase of treasury shares | ( | |||||||||||||
| Proceeds from (purchase of) non-controlling interest | ( | |||||||||||||
| Proceeds from issuance of long-term debt | ||||||||||||||
| Repayment of long-term debt | ( | ( | ||||||||||||
| Net borrowing of commercial paper | ||||||||||||||
| Net repayment of short-term debt | ( | ( | ||||||||||||
| Repayment of lease liabilities | ( | ( | ||||||||||||
| Share buyback/cancellations | ( | ( | ||||||||||||
| Dividends paid | ( | ( | ||||||||||||
| Net cash used in financing activities | ( | ( | ||||||||||||
| Effect of exchange rates on cash and cash equivalents | ( | |||||||||||||
| Net decrease in cash and cash equivalents | ( | ( | ||||||||||||
| Cash and cash equivalents balance at beginning of year | ||||||||||||||
| Cash and cash equivalents balance at end of period | $ | $ | ||||||||||||
| Supplemental cash flow information: | ||||||||||||||
| Interest paid, net of amounts capitalized | $ | $ | ||||||||||||
| Income taxes paid | $ | $ | ||||||||||||
| Supplemental non-cash disclosures relating to investing and financing activities: | ||||||||||||||
| Purchase of property and equipment, accrued but unpaid | $ | $ | ||||||||||||
See accompanying notes to condensed consolidated financial statements.
8
Amcor plc and Subsidiaries
Condensed Consolidated Statements of Equity
(Unaudited)
| ($ in millions, except per share data) | Ordinary Shares | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Loss | Treasury Shares | Non-controlling Interest | Total | |||||||||||||||||||||||||||||||||||||
| Balance as of December 31, 2019 | $ | $ | $ | $ | ( | $ | ( | $ | $ | |||||||||||||||||||||||||||||||||||
| Net income | ||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss | ( | ( | ||||||||||||||||||||||||||||||||||||||||||
| Share buyback/cancellations | ( | ( | ||||||||||||||||||||||||||||||||||||||||||
Dividends declared ($ | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||
| Share-based compensation expense | ||||||||||||||||||||||||||||||||||||||||||||
| Balance as of March 31, 2020 | $ | $ | $ | $ | ( | $ | ( | $ | $ | |||||||||||||||||||||||||||||||||||
| Balance as of June 30, 2019 | $ | $ | $ | $ | ( | $ | ( | $ | $ | |||||||||||||||||||||||||||||||||||
| Net income | ||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss | ( | — | ( | |||||||||||||||||||||||||||||||||||||||||
| Share buyback/cancellations | ( | ( | ||||||||||||||||||||||||||||||||||||||||||
Dividends declared ($ | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||
| Options exercised and shares vested | ( | |||||||||||||||||||||||||||||||||||||||||||
| Purchase of treasury shares | ( | ( | ||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation expense | ||||||||||||||||||||||||||||||||||||||||||||
| Change in non-controlling interest | — | |||||||||||||||||||||||||||||||||||||||||||
Cumulative adjustment related to the adoption of | ||||||||||||||||||||||||||||||||||||||||||||
| Balance as of March 31, 2020 | $ | $ | $ | $ | ( | $ | ( | $ | $ | |||||||||||||||||||||||||||||||||||
| Balance as of December 31, 2020 | $ | $ | $ | $ | ( | $ | ( | $ | $ | |||||||||||||||||||||||||||||||||||
| Net income | ||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||
| Share buyback/cancellations | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||
Dividends declared ($ | ( | — | ( | |||||||||||||||||||||||||||||||||||||||||
| Options exercised and shares vested | ( | |||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation expense | ||||||||||||||||||||||||||||||||||||||||||||
| Balance as of March 31, 2021 | $ | $ | $ | ( | $ | ( | $ | $ | ||||||||||||||||||||||||||||||||||||
| Balance as of June 30, 2020 | $ | $ | $ | $ | ( | $ | ( | $ | $ | |||||||||||||||||||||||||||||||||||
| Net income | ||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | — | |||||||||||||||||||||||||||||||||||||||||||
| Share buyback/cancellations | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||
Dividends declared ($ | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||
| Options exercised and shares vested | ( | |||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation expense | ||||||||||||||||||||||||||||||||||||||||||||
| Change in non-controlling interest | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||
Cumulative adjustment related to the adoption of (1) | ( | ( | ||||||||||||||||||||||||||||||||||||||||||
| Balance as of March 31, 2021 | $ | $ | $ | $ | ( | $ | ( | $ | $ | |||||||||||||||||||||||||||||||||||
(1)Refer to Note 2, "New Accounting Guidance" for more information.
See accompanying notes to condensed consolidated financial statements.
9
Amcor plc and Subsidiaries
Notes to Condensed Consolidated Financial Statements
Note 1 - Nature of Operations and Basis of Presentation
Amcor plc ("Amcor" or the "Company") is a global packaging company that employs approximately 47,000 people across approximately 230 principal manufacturing sites in more than 40 countries. The Company develops and produces a broad range of packaging products including flexible packaging and rigid packaging containers.
Note 2 - New Accounting Guidance
Recently Adopted Accounting Standards
In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13, which is guidance requiring financial assets, or a group of financial assets measured at amortized cost basis to be presented at the net amount expected to be collected when finalized using a loss methodology known as the current expected credit loss methodology ("CECL"). The allowance for credit losses is a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. This updated guidance impacts loans, debt securities, trade receivables, net investments in leases, off-balance-sheet credit exposures, reinsurance receivables and any other financial assets not excluded from the scope that have the contractual right to receive cash. The guidance was effective for the Company on July 1, 2020 and was adopted using the modified retrospective approach. As a result, the Company changed its disclosures related to credit losses; refer to Note 9, "Trade Receivables, Net."
| ($ in millions) | June 30, 2020 | Adjustments Due to Adoption | July 1, 2020 | |||||||||||||||||
| Trade receivables, net | $ | $ | ( | $ | ||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Retained earnings | ( | |||||||||||||||||||
Accounting Standards Not Yet Adopted
In December 2019, the FASB issued updated guidance to simplify the accounting for income taxes by removing certain exceptions and improving the consistent application of U.S. GAAP in other tax accounting areas. This guidance is effective for annual reporting periods, and any interim periods within those annual periods, that begin after December 15, 2020 with early adoption permitted. The Company is currently evaluating the effects adoption of this guidance will have on the consolidated financial statements and does not expect the adoption will be material to its consolidated financial statements and related disclosures when adopted on July 1, 2021.
In March 2020, the FASB issued optional expedients and exceptions to ease the potential burden in accounting for reference rate reform related to contract modifications, hedging relationships, and other transactions that reference the London
10
Interbank Offered Rate ("LIBOR") or another reference rate expected to be discontinued, subject to meeting certain criteria. The Company is currently evaluating its agreements and the optional expedients provided by the new standard.
The Company considers the applicability and impact of all ASUs issued by the FASB. The Company determined that all other ASUs not yet adopted to be either not applicable or are expected to have minimal impact on the Company's consolidated financial statements at this time.
Note 3 - Discontinued Operations
On February 11, 2019, the Company received approval from the European Commission ("EC") for the acquisition of Bemis Company, Inc. ("Bemis"). A condition of the approval was an agreement to divest three Bemis medical packaging facilities located in the United Kingdom and Ireland ("EC Remedy"). Upon completion of the Bemis acquisition on June 11, 2019, the Company determined that the EC Remedy met the criteria to be classified as a discontinued operation, in accordance with ASC 205-20, "Discontinued Operations." The sale of the EC Remedy closed on August 8, 2019. The Company recorded a loss on the sale of $9 million, which is the result of the reclassification of accumulated foreign currency translation amounts from accumulated other comprehensive loss to earnings from discontinued operations upon sale of the EC Remedy.
The following table summarizes the results of the Company's discontinued operations:
| Nine Months Ended March 31, | ||||||||||||||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||||||||||||||
| Net sales | $ | $ | ||||||||||||||||||||||||
| Loss from discontinued operations | ( | |||||||||||||||||||||||||
| Tax expense on discontinued operations | ( | |||||||||||||||||||||||||
| Loss from discontinued operations, net of tax | $ | $ | ( | |||||||||||||||||||||||
Note 4 - Restructuring Plans
2019 Bemis Integration Plan
In connection with the acquisition of Bemis, the Company initiated restructuring activities in the fourth quarter of 2019 aimed at integrating and optimizing the combined organization. As previously announced, the Company continues to target realizing approximately $180 million of pre-tax synergies driven by procurement, supply chain, and general and administrative savings by the end of fiscal year 2022.
The Company's total 2019 Bemis Integration Plan pre-tax integration costs are expected to be approximately $200 million. The total 2019 Bemis Integration Plan costs include approximately $160 million of restructuring and related expenses, net, and $40 million of general integration expenses. The Company estimates that net cash expenditures including disposal proceeds will be approximately $150 million, of which $40 million relates to general integration expense. As of March 31, 2021, the Company has incurred $94 million in employee related expenses, $28 million in fixed asset related expenses, $19 million in other restructuring and $22 million in restructuring related expenses, partially offset by a gain on disposal of a business of $52 million. The nine months ended March 31, 2021 resulted in net cash inflows of $26 million, including $78 million of business disposal proceeds, offset by $52 million of cash outflows, of which $45 million were payments related to restructuring and related expenditures. Cash payments of approximately $20 million to $30 million are expected for the balance of the fiscal year for restructuring and related expenses. The 2019 Bemis Integration Plan relates to the Flexibles segment and Corporate and is expected to be substantially completed by the end of fiscal year 2022.
11
2018 Rigid Packaging Restructuring Plan
On August 21, 2018, the Company announced a restructuring plan in Amcor Rigid Packaging ("2018 Rigid Packaging Restructuring Plan") aimed at reducing structural costs and optimizing the footprint. The Plan includes the closures of manufacturing facilities and headcount reductions to achieve manufacturing footprint optimization and productivity improvements as well as overhead cost reductions.
The Company's total 2018 Rigid Packaging Restructuring Plan pre-tax restructuring costs are expected to be approximately $120 million with the main component being the cost to exit manufacturing facilities and employee related costs. The Company estimates that approximately $75 million of the $120 million total costs will result in cash expenditures. Cash payments for the nine months ended March 31, 2021 were $17 million, with less than $5 million expected during the remainder of the fiscal year. The 2018 Rigid Packaging Restructuring Plan is expected to be substantially completed during fiscal year 2021.
Other Restructuring Plans
The Company has entered into other individually immaterial restructuring plans ("Other Restructuring Plans"). The Company's restructuring charge related to these plans was a gain of $4 million and a charge of $1 million for the three months ended March 31, 2021 and 2020, respectively, and charges of $5 million and $2 million for the nine months ended March 31, 2021 and 2020, respectively. The Company's total incurred restructuring charge for Other Restructuring Plans primarily relates to the Flexibles reporting segment.
Consolidated Amcor Restructuring Plans
| ($ in millions) | 2018 Rigid Packaging Restructuring Plan | 2019 Bemis Integration Plan | Other Restructuring Plans | Total Restructuring and Related Expenses (1) | ||||||||||||||||||||||
| Fiscal year 2019 net charges to earnings | $ | $ | $ | $ | ||||||||||||||||||||||
| Fiscal year 2020 net charges to earnings | ||||||||||||||||||||||||||
| Fiscal year 2021 first quarter net charges to earnings | ||||||||||||||||||||||||||
| Fiscal year 2021 second quarter net charges to earnings | ||||||||||||||||||||||||||
| Fiscal year 2021 third quarter net charges to earnings | ( | ( | ( | |||||||||||||||||||||||
| Expense incurred to date | $ | $ | $ | $ | ||||||||||||||||||||||
(1)Total restructuring and related expenses includes restructuring related costs from the 2019 Bemis Integration Plan of $2 million, $15 million, $1 million, $4 million and $5 million for fiscal year 2019, fiscal year 2020, first quarter of fiscal year 2021, second quarter of fiscal year 2021 and third quarter of fiscal year 2021, respectively.
12
An analysis of the restructuring charges by type incurred follows:
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| ($ in millions) | March 31, 2021 | March 31, 2020 | March 31, 2021 | March 31, 2020 | ||||||||||||||||||||||
| Employee costs | $ | $ | $ | $ | ||||||||||||||||||||||
| Fixed asset related costs | ||||||||||||||||||||||||||
| Other costs | ||||||||||||||||||||||||||
| Gain on sale of business | ( | ( | ||||||||||||||||||||||||
| Total restructuring costs, net | $ | ( | $ | $ | $ | |||||||||||||||||||||
| ($ in millions) | Employee Costs | Fixed Asset Related Costs | Other Costs | Total Restructuring Costs | ||||||||||||||||||||||
| Liability balance at June 30, 2020 | $ | $ | $ | $ | ||||||||||||||||||||||
| Net charges to earnings | ||||||||||||||||||||||||||
| Cash paid | ( | ( | ( | ( | ||||||||||||||||||||||
| Non-cash and other | ( | ( | ||||||||||||||||||||||||
| Foreign currency translation | ( | |||||||||||||||||||||||||
| Liability balance at March 31, 2021 | $ | $ | $ | $ | ||||||||||||||||||||||
13
Note 5 - Inventories, Net
| ($ in millions) | March 31, 2021 | June 30, 2020 | ||||||||||||
| Raw materials and supplies | $ | $ | ||||||||||||
| Work in process and finished goods | ||||||||||||||
| Less: inventory reserves | ( | ( | ||||||||||||
| Total inventories, net | $ | $ | ||||||||||||
Note 6 - Goodwill and Other Intangible Assets, Net
Goodwill
| ($ in millions) | Flexibles Segment | Rigid Packaging Segment | Total | |||||||||||||||||
| Balance as of June 30, 2020 | $ | $ | $ | |||||||||||||||||
| Disposals | ( | ( | ||||||||||||||||||
| Currency translation | ||||||||||||||||||||
| Balance as of March 31, 2021 | $ | $ | $ | |||||||||||||||||
Other Intangible Assets, Net
| March 31, 2021 | ||||||||||||||||||||
| ($ in millions) | Gross Carrying Amount | Accumulated Amortization and Impairment | Net Carrying Amount | |||||||||||||||||
| Customer relationships | $ | $ | ( | $ | ||||||||||||||||
| Computer software | ( | |||||||||||||||||||
| Other (1) | ( | |||||||||||||||||||
| Balance as of | $ | $ | ( | $ | ||||||||||||||||
| June 30, 2020 | ||||||||||||||||||||
| ($ in millions) | Gross Carrying Amount | Accumulated Amortization and Impairment | Net Carrying Amount | |||||||||||||||||
| Customer relationships | $ | $ | ( | $ | ||||||||||||||||
| Computer software | ( | |||||||||||||||||||
| Other (1) | ( | |||||||||||||||||||
| Balance as of | $ | $ | ( | $ | ||||||||||||||||
(1)Other includes $16
Amortization expense for intangible assets during the three and nine months ended March 31, 2021 were $44 million and $134 million, respectively, and $47 million and $166 million, respectively, for the three and nine months ended March 31, 2020.
14
Note 7 - Fair Value Measurements
The fair values of the Company’s financial assets and financial liabilities listed below reflect the amounts that would be received to sell the assets or paid to transfer the liabilities in an orderly transaction between market participants at the measurement date (exit price).
The Company’s non-derivative financial instruments primarily include cash and cash equivalents, trade receivables, trade payables, short-term debt and long-term debt. At March 31, 2021 and June 30, 2020, the carrying value of these financial instruments, excluding long-term debt, approximates fair value because of the short-term nature of these instruments.
The fair value of long-term debt with variable interest rates approximates its carrying value. The fair value of the Company’s long-term debt with fixed interest rates is based on market prices, if available, or expected future cash flows discounted at the current interest rate for financial liabilities with similar risk profiles.
| March 31, 2021 | June 30, 2020 | |||||||||||||||||||||||||
| Carrying Value | Fair Value | Carrying Value | Fair Value | |||||||||||||||||||||||
| ($ in millions) | (Level 2) | (Level 2) | ||||||||||||||||||||||||
| Total long-term debt with fixed interest rates (excluding commercial paper and finance leases) | $ | $ | $ | $ | ||||||||||||||||||||||
Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis
Additionally, the Company measures and records certain assets and liabilities, including derivative instruments and contingent purchase consideration liabilities, at fair value. The following tables summarize the fair value of these instruments, which are measured at fair value on a recurring basis, by level, within the fair value hierarchy:
| March 31, 2021 | ||||||||||||||||||||||||||
| ($ in millions) | Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||
| Assets | ||||||||||||||||||||||||||
| Commodity contracts | $ | $ | $ | $ | ||||||||||||||||||||||
| Forward exchange contracts | ||||||||||||||||||||||||||
| Interest rate swaps | ||||||||||||||||||||||||||
| Total assets measured at fair value | $ | $ | $ | $ | ||||||||||||||||||||||
| Liabilities | ||||||||||||||||||||||||||
| Contingent purchase consideration liabilities | $ | $ | $ | $ | ||||||||||||||||||||||
| Forward exchange contracts | ||||||||||||||||||||||||||
| Total liabilities measured at fair value | $ | $ | $ | $ | ||||||||||||||||||||||
| June 30, 2020 | ||||||||||||||||||||||||||
| ($ in millions) | Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||
| Assets | ||||||||||||||||||||||||||
| Forward exchange contracts | $ | $ | $ | $ | ||||||||||||||||||||||
| Interest rate swaps | ||||||||||||||||||||||||||
| Total assets measured at fair value | $ | $ | $ | $ | ||||||||||||||||||||||
| Liabilities | ||||||||||||||||||||||||||
| Contingent purchase consideration liabilities | $ | $ | $ | $ | ||||||||||||||||||||||
| Commodity contracts | ||||||||||||||||||||||||||
| Forward exchange contracts | ||||||||||||||||||||||||||
| Total liabilities measured at fair value | $ | $ | $ | $ | ||||||||||||||||||||||
15
Contingent consideration obligations arise from business acquisitions. The Company's contingent consideration liabilities consist of an $11 million liability that is contingent on future royalty income generated by Discma AG, a subsidiary acquired in March 2017, with the $8 million balance relating to consideration for small business acquisitions where payments are contingent on the Company vacating a certain property or performance criteria. The fair value of the contingent purchase consideration liabilities was determined for each arrangement individually. The fair value was determined using the income approach with significant inputs that are not observable in the market. Key assumptions include the discount rates consistent with the level of risk of achievement and probability adjusted financial projections. The expected outcomes are recorded at net present value, which requires adjustment over the life for changes in risks and probabilities. Changes arising from modifications in forecasts related to contingent consideration are expected to be immaterial.
The fair value of contingent purchase consideration liabilities is included in other current liabilities and other non-current liabilities in the unaudited condensed consolidated balance sheets.
Assets and Liabilities Measured and Recorded at Fair Value on a Nonrecurring Basis
In addition to assets and liabilities that are recorded at fair value on a recurring basis, the Company records assets and liabilities at fair value on a nonrecurring basis. The Company measures certain assets, including technology intangible assets, equity method and other investments and other intangible assets at fair value on a nonrecurring basis when they are deemed to be other than temporarily impaired. The fair values of these assets are determined, when applicable, based on valuation techniques using the best information available, and may include quoted market prices, market comparables and discounted cash flow projections.
The Company sold its equity method investment in AMVIG Holdings Limited ("AMVIG") on September 30, 2020. Refer to Note 17, "Disposals."
16
Note 8 - Derivative Instruments
The Company periodically uses derivatives and other financial instruments to hedge exposures to interest rate, commodity and currency risks. The Company does not hold or issue financial instruments for speculative or trading purposes. For hedges that meet the hedge accounting criteria, the Company, at inception, formally designates and documents the instrument as a fair value hedge or a cash flow hedge of a specific underlying exposure. On an ongoing basis, the Company assesses and documents that its hedges have been and are expected to continue to be highly effective.
Interest Rate Risk
The Company’s policy is to manage exposure to interest rate risk by maintaining a mixture of fixed-rate and variable-rate debt, monitoring global interest rates and, where appropriate, hedging floating interest rate exposure or debt at fixed interest rates through various interest rate derivative instruments, including, but not limited to, interest rate swaps, cross-currency interest rate swaps, and interest rate locks. For interest rate swaps that are accounted for as fair value hedges, changes in the fair value of both the hedging instruments and the underlying debt obligations are immediately recognized in interest expense. Changes in the fair value of interest rate swaps that have not been designated as hedging instruments are reported in the accompanying unaudited condensed consolidated statements of income under other non-operating income, net.
At March 31, 2021 and June 30, 2020, the Company had a notional amount of zero and $100 million cross-currency interest rate swaps outstanding, respectively. The Company did not designate the swaps as hedging instruments and thus changes in fair value were immediately recognized in earnings.
As of March 31, 2021, and June 30, 2020, the total notional amount of the Company’s receive-fixed/pay-variable interest rate swaps accounted for as fair value hedges was $852 million and $837 million, respectively.
Foreign Currency Risk
The Company manufactures and sells its products and finances its operations in a number of countries throughout the world and, as a result, is exposed to movements in foreign currency exchange rates. The purpose of the Company’s foreign currency hedging program is to manage the volatility associated with the changes in exchange rates.
To manage this exchange rate risk, the Company utilizes forward contracts. Contracts that qualify for hedge accounting are designated as cash flow hedges of certain forecasted transactions denominated in foreign currencies. The effective portion of the changes in fair value of these instruments is reported in accumulated other comprehensive loss ("AOCI") and reclassified into earnings in the same financial statement line item and in the same period or periods during which the related hedged transactions affect earnings. The ineffective portion is recognized in earnings over the life of the hedging relationship in the same unaudited condensed consolidated statements of income line item as the underlying hedged item. Changes in the fair value of forward contracts that have not been designated as hedging instruments are reported in the accompanying unaudited condensed consolidated statements of income.
As of March 31, 2021, and June 30, 2020, the notional amount of the outstanding forward contracts was $1.1 billion and $1.6 billion, respectively.
Commodity Risk
Certain raw materials used in the Company's production processes are subject to price volatility caused by weather, supply conditions, political and economic variables and other unpredictable factors. The Company's policy is to minimize exposure to price volatility by passing through the commodity price risk to customers, including through the use of fixed price swaps. The Company purchases on behalf of customers fixed price commodity swaps to offset the exposure of price volatility on the underlying sales contracts. These instruments are cash closed out on maturity and the related cost or benefit is passed through to customers. Information about commodity price exposure is derived from supply forecasts submitted by customers
17
| March 31, 2021 | June 30, 2020 | |||||||||||||
| Commodity | Volume | Volume | ||||||||||||
| Aluminum | ||||||||||||||
| PET resin | ||||||||||||||
| ($ in millions) | Balance Sheet Location | March 31, 2021 | June 30, 2020 | |||||||||||||||||
| Assets | ||||||||||||||||||||
| Derivatives in cash flow hedging relationships: | ||||||||||||||||||||
| Commodity contracts | Other current assets | $ | $ | |||||||||||||||||
| Forward exchange contracts | Other current assets | |||||||||||||||||||
| Derivatives in fair value hedging relationships: | ||||||||||||||||||||
| Interest rate swaps | Other current assets | |||||||||||||||||||
| Derivatives not designated as hedging instruments: | ||||||||||||||||||||
| Forward exchange contracts | Other current assets | |||||||||||||||||||
| Total current derivative contracts | ||||||||||||||||||||
| Derivatives in fair value hedging relationships: | ||||||||||||||||||||
| Interest rate swaps | Other non-current assets | |||||||||||||||||||
| Total non-current derivative contracts | ||||||||||||||||||||
| Total derivative asset contracts | $ | $ | ||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Derivatives in cash flow hedging relationships: | ||||||||||||||||||||
| Commodity contracts | Other current liabilities | $ | $ | |||||||||||||||||
| Forward exchange contracts | Other current liabilities | |||||||||||||||||||
| Derivatives not designated as hedging instruments: | ||||||||||||||||||||
| Forward exchange contracts | Other current liabilities | |||||||||||||||||||
| Total current derivative contracts | ||||||||||||||||||||
| Total non-current derivative contracts | ||||||||||||||||||||
| Total derivative liability contracts | $ | $ | ||||||||||||||||||
18
| Location of Gain (Loss) Reclassified from AOCI into Income (Effective Portion) | Gain (Loss) Reclassified from AOCI into Income (Effective Portion) | |||||||||||||||||||||||||||||||
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||||||||||||
| ($ in millions) | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||||||||
| Derivatives in cash flow hedging relationships | ||||||||||||||||||||||||||||||||
| Commodity contracts | Cost of sales | $ | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||||||
| Forward exchange contracts | Net sales | ( | ||||||||||||||||||||||||||||||
| Treasury locks | Interest expense | ( | ( | |||||||||||||||||||||||||||||
| Total | $ | $ | ( | $ | ( | $ | ( | |||||||||||||||||||||||||
| Location of Gain (Loss) Recognized in the Unaudited Condensed Consolidated Statements of Income | Gain (Loss) Recognized in Income for Derivatives Not Designated as Hedging Instruments | |||||||||||||||||||||||||||||||
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||||||||||||
| ($ in millions) | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||||||||
| Derivatives not designated as hedging instruments | ||||||||||||||||||||||||||||||||
| Forward exchange contracts | Other income, net | $ | $ | ( | $ | $ | ( | |||||||||||||||||||||||||
| Cross currency interest rate swaps | Other income, net | ( | ||||||||||||||||||||||||||||||
| Total | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||||||||
| Location of Gain (Loss) Recognized in the Unaudited Condensed Consolidated Statements of Income | Gain (Loss) Recognized in Income for Derivatives in Fair Value Hedging Relationships | |||||||||||||||||||||||||||||||
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||||||||||||
| ($ in millions) | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||||||||
| Derivatives in fair value hedging relationships | ||||||||||||||||||||||||||||||||
| Interest rate swaps | Interest expense | $ | ( | $ | $ | ( | $ | |||||||||||||||||||||||||
| Total | $ | ( | $ | $ | ( | $ | ||||||||||||||||||||||||||
19
Note 9 - Trade Receivables, Net
Trade receivables, net is summarized as follows:
| ($ in millions) | March 31, 2021 | June 30, 2020 | ||||||||||||
| Trade receivables, gross | $ | $ | ||||||||||||
| Less: Allowance for doubtful accounts | ( | ( | ||||||||||||
| Trade receivables, net | $ | $ | ||||||||||||
Allowance for Doubtful Accounts
| Nine Months Ended March 31, | ||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||
| Balance as of June 30 | $ | ( | $ | ( | ||||||||||
Impact of adoption of ("CECL") (1) | ( | — | ||||||||||||
| Recoveries/(charges) to income | ( | |||||||||||||
| Write-offs | ||||||||||||||
| Foreign currency and other | ||||||||||||||
| Balance as of March 31 | $ | ( | $ | ( | ||||||||||
(1)Refer to Note 2, "New Accounting Guidance" for more information.
20
Note 10 - Components of Net Periodic Benefit Cost
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||||||
| ($ in millions) | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||
| Service cost | $ | $ | $ | $ | ||||||||||||||||||||||
| Interest cost | ||||||||||||||||||||||||||
| Expected return on plan assets | ( | ( | ( | ( | ||||||||||||||||||||||
| Amortization of actuarial loss | ||||||||||||||||||||||||||
| Amortization of prior service credit | ( | ( | ( | |||||||||||||||||||||||
| Net periodic benefit cost | $ | $ | $ | $ | ||||||||||||||||||||||
Note 11 - Debt
Note 12 - Income Taxes
Income tax expense for the three and nine months ended March 31, 2021 is $71 million and $187 million, respectively, compared to $56 million and $123 million for the three and nine months ended March 31, 2020, respectively.
21
Note 13 - Shareholders' Equity
| Ordinary Shares | Treasury Shares | |||||||||||||||||||||||||
| (shares and $ in millions) | Number of Shares | Amount | Number of Shares | Amount | ||||||||||||||||||||||
| Balance as of June 30, 2019 | $ | $ | ( | |||||||||||||||||||||||
| Share buy-back/cancellations | ( | — | — | |||||||||||||||||||||||
| Options exercised and shares vested | — | — | ( | |||||||||||||||||||||||
| Purchase of treasury shares | — | — | ( | |||||||||||||||||||||||
| Balance as of March 31, 2020 | $ | $ | ( | |||||||||||||||||||||||
| Balance as of June 30, 2020 | $ | $ | ( | |||||||||||||||||||||||
| Share buy-back/cancellations | ( | ( | ||||||||||||||||||||||||
| Options exercised and shares vested | — | — | ( | |||||||||||||||||||||||
| Balance as of March 31, 2021 | $ | $ | ( | |||||||||||||||||||||||
| Foreign Currency Translation | Net Investment Hedge | Pension | Effective Derivatives | Total Accumulated Other Comprehensive Loss | ||||||||||||||||||||||||||||
| ($ in millions) | (Net of Tax) | (Net of Tax) | (Net of Tax) | (Net of Tax) | ||||||||||||||||||||||||||||
| Balance as of June 30, 2019 | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||||
| Other comprehensive income (loss) before reclassifications | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||
| Amounts reclassified from accumulated other comprehensive loss | ||||||||||||||||||||||||||||||||
| Net current period other comprehensive income (loss) | ( | ( | ( | ( | ||||||||||||||||||||||||||||
| Balance as of March 31, 2020 | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||||
| Balance as of June 30, 2020 | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||||
| Other comprehensive income (loss) before reclassifications | ( | |||||||||||||||||||||||||||||||
| Amounts reclassified from accumulated other comprehensive loss | ||||||||||||||||||||||||||||||||
| Net current period other comprehensive income (loss) | ||||||||||||||||||||||||||||||||
| Balance as of March 31, 2021 | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||||
22
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||||||
| ($ in millions) | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||
| Amortization of pension: | ||||||||||||||||||||||||||
| Amortization of prior service credit | $ | ( | $ | $ | ( | $ | ( | |||||||||||||||||||
| Amortization of actuarial loss | ||||||||||||||||||||||||||
| Total before tax effect | ||||||||||||||||||||||||||
| Tax benefit on amounts reclassified into earnings | ||||||||||||||||||||||||||
| Total net of tax | $ | $ | $ | $ | ||||||||||||||||||||||
| (Gains) losses on cash flow hedges: | ||||||||||||||||||||||||||
| Commodity contracts | $ | ( | $ | $ | $ | |||||||||||||||||||||
| Forward exchange contracts | ||||||||||||||||||||||||||
| Treasury locks | ||||||||||||||||||||||||||
| Total before tax effect | ||||||||||||||||||||||||||
| Tax benefit on amounts reclassified into earnings | ( | ( | ||||||||||||||||||||||||
| Total net of tax | $ | $ | $ | $ | ||||||||||||||||||||||
| (Gains) losses on foreign currency translation: | ||||||||||||||||||||||||||
| Foreign currency translation adjustment (1) | $ | $ | $ | $ | ||||||||||||||||||||||
| Total before tax effect | ||||||||||||||||||||||||||
| Tax benefit on amounts reclassified into earnings | ||||||||||||||||||||||||||
| Total net of tax | $ | $ | $ | $ | ||||||||||||||||||||||
(1) During the nine months ended March 31, 2021, the Company recorded a gain on disposal of AMVIG and other non-core businesses. Upon completion of the sales, $26 million of accumulated foreign currency translation was transferred from accumulated other comprehensive income to earnings. Refer to Note 17, "Disposals" for more information on disposals. During the nine months ended March 31, 2020, the Company recorded a loss on the sale of the EC Remedy of $9 million, which is the result of the reclassification of accumulated foreign currency translation amounts from accumulated other comprehensive loss to earnings. Refer to Note 3, "Discontinued Operations" for more information on the sale of the EC Remedy.
23
Note 14 - Segments
The Company's business is organized and presented in the two
Flexibles: Consists of operations that manufacture flexible and film packaging in the food and beverage, medical and pharmaceutical, fresh produce, snack food, personal care, and other industries.
Rigid Packaging: Consists of operations that manufacture rigid containers for a broad range of predominantly beverage and food products, including carbonated soft drinks, water, juices, sports drinks, milk-based beverages, spirits and beer, sauces, dressings, spreads and personal care items and plastic caps for a wide variety of applications.
Other consists of the Company's undistributed corporate expenses including executive and functional compensation costs, equity method investments, intercompany eliminations and other business activities.
The accounting policies of the reportable segments are the same as those in the consolidated financial statements. During the first quarter of fiscal 2021, the Company revised the presentation of adjusted earnings before interest and tax ("Adjusted EBIT") from continuing operations in the reportable segments to include an allocation of certain research and development and selling, general and administrative expenses that management previously reflected in Other. The Company refines its expense allocation methodologies to the reportable segments periodically as more relevant information becomes available and to align with industry or market changes. Corporate expenses are allocated to the reportable segments based primarily on direct attribution. Prior periods have been recast to conform to the new cost allocation methodology.
24
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||||||
| ($ in millions) | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||
| Sales including intersegment sales | ||||||||||||||||||||||||||
| Flexibles | $ | $ | $ | $ | ||||||||||||||||||||||
| Rigid Packaging | ||||||||||||||||||||||||||
| Total sales including intersegment sales | ||||||||||||||||||||||||||
| Intersegment sales | ||||||||||||||||||||||||||
| Flexibles | ||||||||||||||||||||||||||
| Rigid Packaging | ||||||||||||||||||||||||||
| Total intersegment sales | ||||||||||||||||||||||||||
| Net sales | $ | $ | $ | $ | ||||||||||||||||||||||
| Adjusted EBIT from continuing operations | ||||||||||||||||||||||||||
| Flexibles | $ | $ | $ | $ | ||||||||||||||||||||||
| Rigid Packaging | ||||||||||||||||||||||||||
| Other | ( | ( | ( | ( | ||||||||||||||||||||||
| Adjusted EBIT from continuing operations | ||||||||||||||||||||||||||
| Less: Material restructuring programs (1) | ( | ( | ( | |||||||||||||||||||||||
| Less: Material acquisition costs and other (2) | ( | ( | ( | ( | ||||||||||||||||||||||
| Less: Amortization of acquired intangible assets from business combinations (3) | ( | ( | ( | ( | ||||||||||||||||||||||
| Less: Impact of hyperinflation (4) | ( | ( | ( | ( | ||||||||||||||||||||||
| Add: Net gain on disposals (5) | ||||||||||||||||||||||||||
| EBIT from continuing operations | ||||||||||||||||||||||||||
| Interest income | ||||||||||||||||||||||||||
| Interest expense | ( | ( | ( | ( | ||||||||||||||||||||||
| Equity in income of affiliated companies, net of tax | ( | ( | ( | |||||||||||||||||||||||
| Income from continuing operations before income taxes and equity in income of affiliated companies | $ | $ | $ | $ | ||||||||||||||||||||||
(1)Material restructuring programs includes restructuring and related expenses for the 2018 Rigid Packaging Restructuring Plan and the 2019 Bemis Integration Plan for the three and nine months ended March 31, 2021 and 2020. Refer to Note 4, "Restructuring Plans," for more information about the Company's restructuring plans.
(2)Material acquisition costs and other includes Bemis transaction related costs and integration costs not qualifying as exit costs for the nine months ended March 31, 2021. Material acquisition costs and other for the nine months ended March 31, 2020 includes $58 million amortization of Bemis acquisition related inventory fair value step-up and $58 million of Bemis transaction related costs and integration costs not qualifying as exit costs.
(3)Amortization of acquired intangible assets from business combinations includes amortization expenses related to all acquired intangible assets from acquisitions impacting the periods presented, including $26 million of sales backlog amortization for the nine months ended March 31, 2020 from the Bemis acquisition.
(4)Impact of hyperinflation includes the adverse impact of highly inflationary accounting for subsidiaries in Argentina where the functional currency was the Argentine Peso.
(5)Net gain on disposals includes the gain realized upon the disposal of AMVIG and the loss upon disposal of other non-core businesses not part of material restructuring programs. Refer to Note 17, "Disposals" for more information about the Company's disposals.
25
| Net Sales | Three Months Ended March 31, | |||||||||||||||||||||||||||||||||||||
| 2021 | 2020 | |||||||||||||||||||||||||||||||||||||
| ($ in millions) | Flexibles | Rigid Packaging | Total | Flexibles | Rigid Packaging | Total | ||||||||||||||||||||||||||||||||
| North America | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
| Latin America | ||||||||||||||||||||||||||||||||||||||
| Europe | ||||||||||||||||||||||||||||||||||||||
| Asia Pacific | ||||||||||||||||||||||||||||||||||||||
| Net sales | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
| Net Sales | Nine Months Ended March 31, | |||||||||||||||||||||||||||||||||||||
| 2021 | 2020 | |||||||||||||||||||||||||||||||||||||
| ($ in millions) | Flexibles | Rigid Packaging | Total | Flexibles | Rigid Packaging | Total | ||||||||||||||||||||||||||||||||
| North America | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
| Latin America | ||||||||||||||||||||||||||||||||||||||
| Europe | ||||||||||||||||||||||||||||||||||||||
| Asia Pacific | ||||||||||||||||||||||||||||||||||||||
| Net sales | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
26
Note 15 - Earnings Per Share Computations
The Company applies the two-class method when computing its earnings per share ("EPS"), which requires that net income per share for each class of share be calculated assuming all of the Company's net income is distributed as dividends to each class of share based on their contractual rights.
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||||||||||||||||||
| (in millions, except per share amounts) | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||||||||||||||
| Numerator | ||||||||||||||||||||||||||||||||||||||
| Net income attributable to Amcor plc | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
| Distributed and undistributed earnings attributable to shares to be repurchased | ( | |||||||||||||||||||||||||||||||||||||
| Net income available to ordinary shareholders of Amcor plc—basic and diluted | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
| Net income available to ordinary shareholders of Amcor plc from continuing operations—basic and diluted | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
| Net income available to ordinary shareholders of Amcor plc from discontinued operations—basic and diluted | $ | $ | $ | $ | ( | |||||||||||||||||||||||||||||||||
| Denominator | ||||||||||||||||||||||||||||||||||||||
| Weighted-average ordinary shares outstanding | ||||||||||||||||||||||||||||||||||||||
| Weighted-average ordinary shares to be repurchased by Amcor plc | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||
| Weighted-average ordinary shares outstanding for EPS—basic | ||||||||||||||||||||||||||||||||||||||
| Effect of dilutive shares | ||||||||||||||||||||||||||||||||||||||
| Weighted-average ordinary shares outstanding for EPS—diluted | ||||||||||||||||||||||||||||||||||||||
| Per ordinary share income | ||||||||||||||||||||||||||||||||||||||
| Income from continuing operations | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
| Income from discontinued operations | ( | |||||||||||||||||||||||||||||||||||||
| Basic earnings per ordinary share | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
| Income from continuing operations | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
| Income from discontinued operations | ( | |||||||||||||||||||||||||||||||||||||
| Diluted earnings per ordinary share | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
Note: Per share amounts are computed independently for each of the quarters presented. The sum of the quarters may not equal the total year amount due to the impact of changes in average quarterly shares outstanding and all other quarterly amounts may not equal the total year due to rounding.
Certain outstanding share options were excluded from the diluted earnings per share calculation because they were anti-dilutive. The excluded share options for the three and nine months ended March 31, 2021, represented an aggregate of 1.8 million and 8.2 million shares, respectively. The excluded share options for the three and nine months ended March 31, 2020, represented an aggregate of 53.6 million and 31.4 million shares, respectively.
27
Note 16 - Contingencies and Legal Proceedings
Contingencies - Brazil
The Company's operations in Brazil are involved in various governmental assessments and litigation, principally related to claims for excise and income taxes. The Company vigorously defends its positions and believes it will prevail on most, if not all, of these matters. The Company does not believe that the ultimate resolution of these matters will materially impact the Company's consolidated results of operations, financial position or cash flows. Under customary local regulations, the Company's Brazilian subsidiaries may need to post cash or other collateral if a challenge to any administrative assessment proceeds to the Brazilian court system; however, the level of cash or collateral already pledged or potentially required to be pledged would not significantly impact the Company's liquidity. At March 31, 2021 and June 30, 2020, the Company has recorded accruals of $11 million and $12 million, respectively, included in other non-current liabilities in the unaudited condensed consolidated balance sheets, and has estimated a reasonably possible loss exposure in excess of the accrual of $18 million at March 31, 2021 and June 30, 2020, respectively. The litigation process is subject to many uncertainties and the outcome of individual matters cannot be accurately predicted. The Company routinely assesses these matters as to probability of ultimately incurring a liability and records the best estimate of the ultimate loss in situations where the likelihood of an ultimate loss is probable. The Company's assessments are based on its knowledge and experience, but the ultimate outcome of any of these matters may differ from the Company's estimates.
As of March 31, 2021, Amcor has provided letters of credit of $32 million, judicial insurance of $1 million, and deposited cash of $10 million with the courts to continue to defend the cases.
Contingencies - Environmental Matters
The Company, along with others, has been identified as a potentially responsible party ("PRP") at several waste disposal sites under U.S. federal and related state environmental statutes and regulations and may face potentially material environmental remediation obligations. While the Company benefits from various forms of insurance policies, actual coverage may not, or only partially, cover the total potential exposures. The Company has recorded $17 million aggregate accruals for its share of estimated future remediation costs at these sites.
In addition to the matters described above, the Company has also recorded aggregate accruals of $50 million for potential liabilities for remediation obligations at various worldwide locations that are owned or operated by the Company, or were formerly owned or operated.
While the Company believes that its accruals are adequate to cover its future obligations, there can be no assurance that the ultimate payments will not exceed the accrued amounts. Nevertheless, based on the available information, the Company does not believe that its potential environmental obligations will have a material adverse effect upon its liquidity, results of operations or financial condition.
Other Matters
In the normal course of business, the Company is subject to legal proceedings, lawsuits and other claims. While the potential financial impact with respect to these ordinary course matters is subject to many factors and uncertainties, management believes that any financial impact to the Company from these matters, individually and in the aggregate, would not have a material adverse effect on the Company's financial position or results of operation.
Note 17 - Disposals
28
Note 18 - Subsequent Events
29
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Management’s Discussion and Analysis ("M,D&A") should be read in conjunction with the Financial Statements and Notes to Condensed Consolidated Financial Statements. Throughout the M,D&A, amounts and percentages may not recalculate due to rounding.
Summary of Financial Results
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||||||||||||||||||||||||||||||
| ($ in millions) | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||||||||||||||||||||||||||
| Net sales | $ | 3,207 | 100.0 | % | $ | 3,141 | 100.0 | % | $ | 9,407 | 100.0 | % | $ | 9,325 | 100.0 | % | ||||||||||||||||||||||||||||||||||
| Cost of sales | (2,525) | (78.7 | %) | (2,489) | (79.2 | %) | (7,420) | (78.9 | %) | (7,509) | (80.5 | %) | ||||||||||||||||||||||||||||||||||||||
| Gross profit | 682 | 21.3 | % | 652 | 20.8 | % | 1,987 | 21.1 | % | 1,816 | 19.5 | % | ||||||||||||||||||||||||||||||||||||||
| Operating expenses: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Selling, general and administrative expenses | (325) | (10.1 | %) | (354) | (11.3 | %) | (962) | (10.2 | %) | (1,034) | (11.1 | %) | ||||||||||||||||||||||||||||||||||||||
| Research and development expenses | (25) | (0.8 | %) | (25) | (0.8 | %) | (74) | (0.8 | %) | (74) | (0.8 | %) | ||||||||||||||||||||||||||||||||||||||
| Restructuring and related expenses, net | 24 | 0.7 | % | (20) | (0.6 | %) | (22) | (0.2 | %) | (62) | (0.7 | %) | ||||||||||||||||||||||||||||||||||||||
| Other income, net | 17 | 0.5 | % | 18 | 0.6 | % | 27 | 0.3 | % | 38 | 0.4 | % | ||||||||||||||||||||||||||||||||||||||
| Operating income | 373 | 11.6 | % | 271 | 8.6 | % | 956 | 10.2 | % | 684 | 7.3 | % | ||||||||||||||||||||||||||||||||||||||
| Interest income | 3 | 0.1 | % | 5 | 0.2 | % | 10 | 0.1 | % | 18 | 0.2 | % | ||||||||||||||||||||||||||||||||||||||
| Interest expense | (36) | (1.1 | %) | (46) | (1.5 | %) | (113) | (1.2 | %) | (158) | (1.7 | %) | ||||||||||||||||||||||||||||||||||||||
| Other non-operating income, net | 1 | — | % | 6 | 0.2 | % | 7 | 0.1 | % | 18 | 0.2 | % | ||||||||||||||||||||||||||||||||||||||
| Income from continuing operations before income taxes and equity in income of affiliated companies | 341 | 10.6 | % | 236 | 7.5 | % | 860 | 9.1 | % | 562 | 6.0 | % | ||||||||||||||||||||||||||||||||||||||
| Income tax expense | (71) | (2.2 | %) | (56) | (1.8 | %) | (187) | (2.0 | %) | (123) | (1.3 | %) | ||||||||||||||||||||||||||||||||||||||
| Equity in income of affiliated companies, net of tax | — | — | 3 | 0.1 | % | 19 | 0.2 | % | 8 | 0.1 | % | |||||||||||||||||||||||||||||||||||||||
| Income from continuing operations | 270 | 8.4 | % | 183 | 5.8 | % | 692 | 7.4 | % | 447 | 4.8 | % | ||||||||||||||||||||||||||||||||||||||
| Loss from discontinued operations, net of tax | — | — | — | — | — | — | (8) | (0.1 | %) | |||||||||||||||||||||||||||||||||||||||||
| Net income | $ | 270 | 8.4 | % | $ | 183 | 5.8 | % | $ | 692 | 7.4 | % | $ | 439 | 4.7 | % | ||||||||||||||||||||||||||||||||||
| Net income attributable to non-controlling interests | (3) | (0.1 | %) | (2) | (0.1 | %) | (8) | (0.1 | %) | (6) | (0.1 | %) | ||||||||||||||||||||||||||||||||||||||
| Net income attributable to Amcor plc | $ | 267 | 8.3 | % | $ | 181 | 5.8 | % | $ | 684 | 7.3 | % | $ | 433 | 4.6 | % | ||||||||||||||||||||||||||||||||||
30
Overview
Amcor is a global packaging company with total sales of approximately $12.5 billion in fiscal year 2020. We employ approximately 47,000 people across approximately 230 principal manufacturing sites in more than 40 countries, and are a leader in developing and producing a broad range of packaging products including flexible and rigid packaging, specialty cartons and closures. In fiscal year 2020, the majority of sales were made to the food, beverage, pharmaceutical, medical device, home and personal care, and other consumer goods end markets.
Significant Items Affecting the Periods Presented
Impact of COVID-19
The 2019 Novel Coronavirus ("COVID-19") has resulted in a period of historic uncertainty and challenges with the extent and severity of the pandemic continuing to vary among the various regions in which we operate. Amcor’s business is almost entirely exposed to end markets which have demonstrated the same resilience experienced through past economic cycles. Our scale and global footprint has enabled us to collaborate with customers and suppliers to meet volatile changes in demand and continue to service our customers. We believe we are well-positioned to continue to meet the challenges of the COVID-19 pandemic. However, we cannot reasonably estimate the duration and severity of this pandemic or its ultimate impact on the global economy and our operations and financial results. The ultimate near-term impact of the pandemic on our business will depend on the extent and nature of any future disruptions across the supply chain, government imposed restrictions on consumer mobility and the pace of macroeconomic recovery in key global economies. Our priorities during the COVID-19 pandemic continue to be protecting the health and safety of our employees and effectively managing our operations and supply chains to meet the needs of our customers.
Amcor’s commitment to the health and safety of its employees remains our first priority. Our rigorous precautionary measures include the formation of global and regional response teams that maintain contact with authorities and experts to actively manage the situation, restrictions on company travel, quarantine protocols for employees who may have had exposure or have symptoms, frequent disinfecting of Amcor locations and other measures designed to help protect employees, customers and suppliers. We expect to continue these measures until the COVID-19 pandemic is adequately contained for our business.
Operations and Supply Chain
While we have experienced isolated disruptions to our operations to date, our manufacturing facilities have largely been deemed as providing essential services and continue to supply our customers. We also have not experienced any material disruptions in our supply chain to date as a result of COVID-19. However, we have experienced continued volatility in customer order patterns and could continue to experience significant volatility in the demand for our products in the future. Our facilities have largely been exempt from government mandated closure orders. While governmental measures may be modified, we expect that our facilities will remain operational given the essential products we supply. However, despite our best efforts to contain the impact in our facilities, it remains possible that significant disruptions could occur as a result of the pandemic, including temporary closures of our facilities.
During the third fiscal quarter of 2021, there were significant winter storms across the southern United States and other global factors which resulted in supply disruptions of certain resins and raw materials and increased price volatility of certain raw materials across many of the regions in which we operate for both of our reportable segments. We were able to work closely with our suppliers and customers, leveraging our global capabilities and expertise to work through supply and other resulting issues and the impact on our third quarter fiscal 2021 results was not material. While we expect to continue to be able to successfully navigate through any supply disruptions and raw material price volatility during the fourth fiscal quarter of 2021, future weather events and other factors, including disruption of transportation systems for our products, are inherently uncertain and could have an adverse impact on our operating results.
2019 Bemis Integration Plan
In connection with the acquisition of Bemis, the Company initiated restructuring activities in the fourth quarter of 2019 aimed at integrating and optimizing the combined organization. As previously announced, the Company continues to target realizing approximately $180 million of pre-tax synergies driven by procurement, supply chain, and general and administrative savings by the end of fiscal year 2022.
31
The Company's total 2019 Bemis Integration Plan pre-tax integration costs are expected to be approximately $200 million. The total 2019 Bemis Integration Plan costs include approximately $160 million of restructuring and related expenses, net, and $40 million of general integration expenses. The Company estimates that net cash expenditures including disposal proceeds will be approximately $150 million, of which $40 million relates to general integration expense. As of March 31, 2021, the Company has incurred $94 million in employee related expenses, $28 million in fixed asset related expenses, $19 million in other restructuring and $22 million in restructuring related expenses, partially offset by a gain on disposal of a business of $52 million. The nine months ended March 31, 2021, resulted in net cash inflows of $26 million, including $78 million of business disposal proceeds, offset by $52 million of cash outflows, of which $45 million were payments related to restructuring and related expenditures. Cash payments of approximately $20 million to $30 million are expected for the balance of the fiscal year for restructuring and related expenses. The 2019 Bemis Integration Plan relates to the Flexibles segment and Corporate and is expected to be substantially completed by the end of fiscal year 2022.
Restructuring related costs are directly attributable to restructuring activities; however, they do not qualify for special accounting treatment as exit or disposal activities. General integration costs are not linked to restructuring. The Company believes the disclosure of restructuring related costs provides more information on the total cost of our 2019 Bemis Integration Plan. The restructuring related costs relate primarily to the closure of facilities and include costs to replace graphics, train new employees on relocated equipment and anticipated loss on sale of closed facilities.
2018 Rigid Packaging Restructuring Plan
On August 21, 2018, the Company announced a restructuring plan in Amcor Rigid Packaging ("2018 Rigid Packaging Restructuring Plan") aimed at reducing structural costs and optimizing the footprint. The Plan includes the closures of manufacturing facilities and headcount reductions to achieve manufacturing footprint optimization and productivity improvements as well as overhead cost reductions.
The Company's total 2018 Rigid Packaging Restructuring Plan pre-tax restructuring costs are expected to be approximately $120 million with the main component being the cost to exit manufacturing facilities and employee related costs. The Company estimates that approximately $75 million of the $120 million total costs will result in cash expenditures. Cash payments for the nine months ended March 31, 2021 were $17 million, with less than $5 million expected during the remainder of the fiscal year. The 2018 Rigid Packaging Restructuring Plan is expected to be substantially completed during fiscal 2021.
For more information about our restructuring plans, refer to Note 4, "Restructuring Plans" of "Item 1. Financial Statements - Notes to Condensed Consolidated Financial Statements".
High Inflation Accounting
We have subsidiaries in Argentina that historically had a functional currency of the Argentine Peso. As of June 30, 2018, the Argentine economy was designated as highly inflationary for accounting purposes. Accordingly, beginning July 1, 2018, we began reporting the financial results of our Argentinean subsidiaries with a functional currency of the Argentine Peso at the functional currency of the parent, which is the U.S. dollar. Highly inflationary accounting in the three months ended March 31, 2021 and 2020 resulted in a negative impact of $7 million and $5 million, respectively, and $17 million and $23 million in the nine months ended March 31, 2021 and 2020, respectively, in foreign currency transaction losses that was reflected on the unaudited condensed consolidated statements of income.
32
Results of Operations - Three Months Ended March 31, 2021
Consolidated Results of Operations
| Three Months Ended March 31, | ||||||||||||||
| ($ in millions, except per share data) | 2021 | 2020 | ||||||||||||
| Net sales | $ | 3,207 | $ | 3,141 | ||||||||||
| Operating income | 373 | 271 | ||||||||||||
| Operating profit as a percentage of net sales | 11.6 | % | 8.6 | % | ||||||||||
| Net income attributable to Amcor plc | $ | 267 | $ | 181 | ||||||||||
| Diluted Earnings Per Share | $ | 0.173 | $ | 0.114 | ||||||||||
Net sales increased $66 million, or approximately 2%, to $3,207 million for the three months ended March 31, 2021, from $3,141 million for the three months ended March 31, 2020. Excluding the impact of disposed operations of $19 million, or (0.6%), positive currency impacts of $62 million, or 2.0% and pass-through of raw material costs of $16 million, or 0.5%, the increase in net sales for the three months ended March 31, 2021 was $7 million or 0.2%, driven by favorable price mix of 0.6% and unfavorable volumes of (0.4%).
Net income attributable to Amcor plc increased $86 million, or 48%, to $267 million for the three months ended March 31, 2021, from $181 million for the three months ended March 31, 2020 mainly as a result of gross profit margin improvement, Bemis acquisition related synergies and lower restructuring costs and reduced interest expense, partially offset by associated tax charges.
Diluted earnings per share increased to $0.173 for the three months ended March 31, 2021, from $0.114 for the three months ended March 31, 2020, with the net income attributable to ordinary shareholders of Amcor plc increasing by 48% and the diluted weighted average number of shares outstanding decreasing 3% for the three months ended March 31, 2021 compared to the three months ended March 31, 2020. The decrease in the diluted weighted average number of shares outstanding was due to repurchase of shares under announced share buyback programs.
Segment Results of Operations
During the first quarter of fiscal 2021, management has revised the presentation of adjusted earnings before interest and tax ("Adjusted EBIT") from continuing operations in the reportable segments to include an allocation of certain research and development and selling, general and administrative expenses that management previously reflected in Other. Prior periods have been recast to conform to the new cost allocation methodology. For further discussion, refer to Note 14, "Segments."
Flexibles Segment
Our Flexibles reporting segment develops and supplies flexible packaging globally.
| Three Months Ended March 31, | ||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||
| Net sales including intersegment sales | $ | 2,500 | $ | 2,434 | ||||||||||
| Adjusted EBIT from continuing operations | 352 | 317 | ||||||||||||
| Adjusted EBIT from continuing operations as a percentage of net sales | 14.1 | % | 13.0 | % | ||||||||||
Net sales including intersegment sales increased $66 million, or 2.7%, to $2,500 million for the three months ended March 31, 2021, from $2,434 million for the three months ended March 31, 2020. Excluding the impact of disposed operations of $19 million, or (0.8%), positive currency impacts of $70 million, or 2.9%, and pass-through of raw material costs of $23 million, or 1.0%, the decrease in net sales including intersegment sales for the three months ended March 31, 2021, was $9 million, or (0.4%), driven by favorable price/mix of 0.4% and unfavorable volumes of (0.8%).
Adjusted EBIT increased $35 million, or 11.1%, to $352 million for the three months ended March 31, 2021, from $317 million for the three months ended March 31, 2020. Excluding the impact of disposed operations of $1 million, or (0.2%), positive currency impacts of $8 million, or 2.4%, the increase in Adjusted EBIT for the three months ended March 31, 2021, was $28 million, or 8.9%, driven by plant cost improvements of 10.5%, favorable selling, general and administrative ("SG&A") and other cost impacts of 4.4%, partially offset by unfavorable price/mix of (4.7%), and unfavorable volumes of (1.3%).
33
Rigid Packaging Segment
Our Rigid Packaging reporting segment manufactures rigid packaging containers and related products in the Americas.
| Three Months Ended March 31, | ||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||
| Net sales including intersegment sales | $ | 707 | $ | 707 | ||||||||||
| Adjusted EBIT from continuing operations | 75 | 70 | ||||||||||||
| Adjusted EBIT from continuing operations as a percentage of net sales | 10.6 | % | 9.9 | % | ||||||||||
Net sales including intersegment sales were stable at $707 million for the three months ended March 31, 2021, when compared with the three months ended March 31, 2020. Excluding negative currency impacts of $8 million, or (1.3%) and pass-through of raw material costs of $7 million, or (0.9%), the increase in net sales including intersegment sales for the three months ended March 31, 2021 was $15 million, or 2.2%, driven by favorable volumes of 1.2%, and favorable price/mix of 1.0%.
Adjusted EBIT increased $5 million, or 6.7%, to $75 million for the three months ended March 31, 2021, from $70 million for the three months ended March 31, 2020. Excluding negative currency impacts of $1 million, or (1.4%), the increase in Adjusted EBIT for the three months ended March 31, 2021 was $6 million, or 8.3%, driven by favorable volumes of 1.8%, favorable price/mix of 7.8%, favorable plant costs of 2.6%, and unfavorable SG&A and other costs of (3.9%).
Consolidated Gross Profit
| Three Months Ended March 31, | ||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||
| Gross profit | $ | 682 | $ | 652 | ||||||||||
| Gross profit as a percentage of net sales | 21 | % | 21 | % | ||||||||||
Gross profit increased by $30 million, or 4.6%, to $682 million for the three months ended March 31, 2021, from $652 million for the three months ended March 31, 2020. The increase was primarily driven by growth in sales volume in the Rigid Packaging reporting segment and the favorable impact of Bemis related synergies and other cost improvements.
Consolidated Selling, General and Administrative Expense
| Three Months Ended March 31, | ||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||
| SG&A expenses | $ | (325) | $ | (354) | ||||||||||
| SG&A expenses as a percentage of net sales | (10.1 | %) | (11.3 | %) | ||||||||||
SG&A expenses decreased by $29 million, or 8.2%, to $325 million for the three months ended March 31, 2021, from $354 million for the three months ended March 31, 2020. The decrease was primarily due to delivery of synergies associated with the Bemis acquisition and other savings initiatives.
Consolidated Restructuring and Related Expenses, Net
| Three Months Ended March 31, | ||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||
| Restructuring and related expenses, net | $ | 24 | $ | (20) | ||||||||||
| Restructuring and related expenses, net, as a percentage of net sales | 0.7 | % | (0.6 | %) | ||||||||||
Restructuring and related expenses, net, decreased by $44 million to an income of $24 million for the three months ended March 31, 2021, from a net expense of $20 million for the three months ended March 31, 2020. The decrease was primarily driven by the gain on disposal of a non-core European hospital supplies business of $52 million.
34
Consolidated Interest Expense
| Three Months Ended March 31, | ||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||
| Interest expense | $ | (36) | $ | (46) | ||||||||||
| Interest expense as a percentage of net sales | (1 | %) | (1 | %) | ||||||||||
Interest expense decreased by $10 million to $36 million for the three months ended March 31, 2021, from $46 million for the three months ended March 31, 2020, mainly driven by use of commercial paper and lower floating interest rates and repayment of higher cost debt and term loans.
35
Results of Operations - Nine Months Ended March 31, 2021
Consolidated Results of Operations
| Nine Months Ended March 31, | ||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||
| Net sales | $ | 9,407 | $ | 9,325 | ||||||||||
| Operating income | $ | 956 | $ | 684 | ||||||||||
| Operating profit as a percentage of net sales | 10.2 | % | 7.3 | % | ||||||||||
| Net income attributable to Amcor plc | $ | 684 | $ | 433 | ||||||||||
| Diluted Earnings Per Share | $ | 0.438 | $ | 0.269 | ||||||||||
Net sales increased $82 million, or 0.9%, to $9,407 million for the nine months ended March 31, 2021, from $9,325 million for the nine months ended March 31, 2020. Excluding the impact of disposed operations of $44 million, or (0.5%), positive currency impacts of $51 million, or 0.5%, and pass-through of raw material cost of $112 million, or (1.2%), the increase in net sales for the nine months ended March 31, 2021 was $187 million, or 2.0%, driven by favorable volumes of 1.8% and favorable price/mix of 0.2%.
Net income attributable to Amcor plc increased $251 million, or 58%, to $684 million for the nine months ended March 31, 2021, from $433 million for the nine months ended March 31, 2020 mainly as a result of gross profit increases driven by sales improvement, Bemis acquisition related synergies and lower transaction costs, and reduced interest expense, partially offset by associated tax charges.
Diluted earnings per share increased to $0.438 for the nine months ended March 31, 2021, from $0.269 for the nine months ended March 31, 2020, with the net income attributable to ordinary shareholders of Amcor plc increasing by 58% and the diluted weighted average number of shares outstanding decreasing 3.1% for the nine months ended March 31, 2021 compared to the nine months ended March 31, 2020. The decrease in the diluted weighted average number of shares outstanding was due to repurchase of shares under announced share buyback programs.
Segment Results of Operations
Flexibles Segment
Our Flexibles reporting segment develops and supplies flexible packaging globally.
| Nine Months Ended March 31, | ||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||
| Net sales including intersegment sales | $ | 7,350 | $ | 7,280 | ||||||||||
| Adjusted EBIT from continuing operations | $ | 1,005 | $ | 919 | ||||||||||
| Adjusted EBIT from continuing operations as a percentage of net sales | 13.7 | % | 12.6 | % | ||||||||||
Net sales including intersegment sales increased $70 million, or 1.0%, to $7,350 million for the nine months ended March 31, 2021, from $7,280 million for the nine months ended March 31, 2020. Excluding the impact of disposed operations of $44 million, or (0.6%), positive currency impacts of $90 million, or 1.2%, pass-through of raw material cost of $14 million, or (0.2%), the increase in net sales for the nine months ended March 31, 2021 was $38 million, or 0.5%, driven by favorable volumes of 1.1% and unfavorable price/mix of (0.6%).
Adjusted earnings before interest and tax from continuing operations ("Adjusted EBIT") increased $86 million, or 9.4%, to $1,005 million for the nine months ended March 31, 2021, from $919 million for the nine months ended March 31, 2020. Excluding the impact of disposed operations of $1 million, or (0.1%), positive currency impacts of $6 million, or 0.7%, the increase in Adjusted EBIT for the nine months ended March 31, 2021 was $80 million, or 8.7%, driven by plant cost improvements of 9.5%, SG&A and other cost improvements of 2.6%, favorable volumes of 1.9%, partially offset by unfavorable price/mix of (5.3%).
36
Rigid Packaging Segment
Our Rigid Packaging reporting segment manufactures rigid packaging containers and related products.
| Nine Months Ended March 31, | ||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||
| Net sales including intersegment sales | $ | 2,059 | $ | 2,047 | ||||||||||
| Adjusted EBIT from continuing operations | $ | 209 | $ | 197 | ||||||||||
| Adjusted EBIT from continuing operations as a percentage of net sales | 10.1 | % | 9.6 | % | ||||||||||
Net sales including intersegment sales increased $12 million, or 0.6%, to $2,059 million for the nine months ended March 31, 2021, from $2,047 million for the nine months ended March 31, 2020. Excluding negative currency impacts of $39 million, or (1.9%) and pass-through of raw material costs of $98 million, or (4.8%), the increase in net sales including intersegment sales for the nine months ended March 31, 2021 was $149 million, or 7.3%, driven by favorable volume of 4.1% and favorable price/mix of 3.2%.
Adjusted EBIT increased $12 million, or 5.9%, to $209 million for the nine months ended March 31, 2021, from $197 million for the nine months ended March 31, 2020. Excluding negative currency impacts of $6 million, or (3.3%), the increase in Adjusted EBIT for the nine months ended March 31, 2021 was $18 million, or 9.4%, driven primarily by favorable volumes of 6.4%, favorable price/mix of 7.7%, partially offset by unfavorable plant costs of (1.8%) and unfavorable SG&A and other costs of (2.8%).
Consolidated Gross Profit
| Nine Months Ended March 31, | ||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||
| Gross profit | $ | 1,987 | $ | 1,816 | ||||||||||
| Gross profit as a percentage of net sales | 21.1 | % | 19.5 | % | ||||||||||
Gross profit increased by $171 million, or 9.4%, to $1,987 million for the nine months ended March 31, 2021, from $1,816 million for the nine months ended March 31, 2020. The increase was primarily driven by growth in sales volume in the Flexibles and Rigid Packaging reporting segments and the non-recurrence of $52 million of amortization of purchase price accounting adjustments for the nine months ended March 31, 2020.
Consolidated Selling, General and Administrative Expense
| Nine Months Ended March 31, | ||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||
| SG&A expenses | $ | (962) | $ | (1,034) | ||||||||||
| SG&A expenses as a percentage of net sales | (10.2 | %) | (11.1 | %) | ||||||||||
SG&A expenses decreased by $72 million, or 7.0%, to $962 million for the nine months ended March 31, 2021, from $1,034 million for the nine months ended March 31, 2020. The decrease was primarily due to one-off amortization of acquired customer backlog in the nine months ended March 31, 2020, together with impact of synergies and other savings.
Consolidated Restructuring and Related Expenses, Net
| Nine Months Ended March 31, | ||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||
| Restructuring and related expenses, net | $ | (22) | $ | (62) | ||||||||||
| Restructuring and related expenses, net, as a percentage of net sales | (0.2 | %) | (0.7 | %) | ||||||||||
Restructuring and related expenses, net, decreased by $40 million, or 64.5%, to $22 million for the nine months ended March 31, 2021, from $62 million for the nine months ended March 31, 2020. The decrease was primarily driven by a gain on disposal of a non-core European hospital supplies business of $52 million.
37
Consolidated Other Income, Net
| Nine Months Ended March 31, | ||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||
| Other income, net | $ | 27 | $ | 38 | ||||||||||
| Other income, net, as a percentage of net sales | 0.3 | % | 0.4 | % | ||||||||||
Other income, net decreased by $11 million, or 28.9%, to $27 million for the nine months ended March 31, 2021, from $38 million for the nine months ended March 31, 2020, mainly driven by a loss on disposal of two non-core businesses.
Consolidated Interest Income
| Nine Months Ended March 31, | ||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||
| Interest income | $ | 10 | $ | 18 | ||||||||||
| Interest income as a percentage of net sales | 0.1 | % | 0.2 | % | ||||||||||
Interest income decreased by $8 million, or 44.4%, to $10 million for the nine months ended March 31, 2021, from $18 million for the nine months ended March 31, 2020, mainly driven by overall decreases in market interest rates.
Consolidated Interest Expense
| Nine Months Ended March 31, | ||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||
| Interest expense | $ | (113) | $ | (158) | ||||||||||
| Interest expense as a percentage of net sales | (1.2 | %) | (1.7 | %) | ||||||||||
Interest expense decreased by $45 million or 28.5%, to $113 million for the nine months ended March 31, 2021, from $158 million for the nine months ended March 31, 2020 mainly driven by use of commercial paper and lower floating interest rates and repayment of higher cost debt and term loans.
Consolidated Other Non-Operating Income, Net
| Nine Months Ended March 31, | ||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||
| Other non-operating income, net | $ | 7 | $ | 18 | ||||||||||
| Other non-operating income, net, as a percentage of net sales | 0.1 | % | 0.2 | % | ||||||||||
Other non-operating income, net decreased by $11 million to a $7 million gain for the nine months ended March 31, 2021, from a $18 million gain for the nine months ended March 31, 2020, mainly driven by lower expected return on Pension assets partially offset by lower pension interest.
Consolidated Income Tax Expense
| Nine Months Ended March 31, | ||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||
| Income tax expense | $ | (187) | $ | (123) | ||||||||||
| Effective income tax rate | 21.7 | % | 21.9 | % | ||||||||||
The provision for income taxes for the three and nine months ended March 31, 2021 and 2020 is based on the Company’s estimated annual effective tax rate for the respective fiscal years before income taxes and equity in income of affiliated companies and adjusted for specific items that are required to be recognized in the period in which they are incurred.
Income tax expense for the three and nine months ended March 31, 2021 is $71 million and $187 million, respectively, compared to $56 million and $123 million for the three and nine months ended March 31, 2020, respectively.
38
The effective tax rate for the nine months ended March 31, 2021 decreased by 0.2 percentage points compared to the nine months ended March 31, 2020, from 21.9% to 21.7%.
Equity in Income of Affiliated Companies, Net of Tax
| Nine Months Ended March 31, | ||||||||||||||
| ($ in millions) | 2021 | 2020 | ||||||||||||
| Equity in income of affiliated companies, net of tax | 19 | 8 | ||||||||||||
Equity in income of affiliated companies, net of tax increased by $11 million for the nine months ended March 31, 2021 due to the sale of the equity investment in AMVIG on September 30, 2020. For further information, refer to Note 17, "Disposals."
39
Presentation of Non-GAAP Information
This Quarterly Report on Form 10-Q refers to non-GAAP financial measures: adjusted earnings before interest and taxes ("Adjusted EBIT") from continuing operations, adjusted net income from continuing operations, and net debt. These non-GAAP financial measures adjust for factors that are unusual or unpredictable. These measures exclude the impact of significant tax reform, certain amounts related to the effect of changes in currency exchange rates, acquisitions, and restructuring, including employee-related costs, equipment relocation costs, accelerated depreciation and the write-down of equipment. These measures also exclude gains or losses on sales of significant property and divestitures, certain litigation matters, and certain acquisition-related expenses, including transaction expenses, due diligence expenses, professional and legal fees, purchase accounting adjustments for inventory, order backlog, intangible amortization, and changes in the fair value of deferred acquisition payments. This adjusted information should not be construed as an alternative to results determined in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). Management of the Company uses the non-GAAP measures to evaluate operating performance and believes that these non-GAAP measures are useful to enable investors and other external parties to perform comparisons of current and historical performance of the Company.
A reconciliation of reported net income attributable to Amcor plc to adjusted EBIT from continuing operations and adjusted net income from continuing operations for the three and nine months ended March 31, 2021 and 2020 is as follows:
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||||||
| ($ in millions) | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||
| Net income attributable to Amcor plc, as reported | $ | 267 | $ | 181 | $ | 684 | $ | 433 | ||||||||||||||||||
| Add: Net income attributable to non-controlling interests | 3 | 2 | 8 | 6 | ||||||||||||||||||||||
| Add: Loss from discontinued operations, net of tax | — | — | — | 8 | ||||||||||||||||||||||
| Income from continuing operations | 270 | 183 | 692 | 447 | ||||||||||||||||||||||
| Add: Income tax expense | 71 | 56 | 187 | 123 | ||||||||||||||||||||||
| Add: Interest expense | 36 | 46 | 113 | 158 | ||||||||||||||||||||||
| Less: Interest income | (3) | (5) | (10) | (18) | ||||||||||||||||||||||
| EBIT from continuing operations | 374 | 280 | 982 | 710 | ||||||||||||||||||||||
| Add: Material restructuring programs (1) | (23) | 19 | 16 | 60 | ||||||||||||||||||||||
| Add: Material acquisition costs and other (2) | 4 | 15 | 17 | 116 | ||||||||||||||||||||||
| Add: Amortization of acquired intangible assets from business combinations (3) | 40 | 41 | 121 | 150 | ||||||||||||||||||||||
| Add: Impact of hyperinflation (4) | 7 | 5 | 17 | 23 | ||||||||||||||||||||||
| Less: Net gain on disposals (5) | — | — | (9) | — | ||||||||||||||||||||||
| Adjusted EBIT from continuing operations | $ | 402 | $ | 360 | $ | 1,144 | $ | 1,059 | ||||||||||||||||||
| Less: Income tax expense | (71) | (56) | (187) | (123) | ||||||||||||||||||||||
| Less: Adjustments to income tax expense (6) | (12) | (16) | (41) | (71) | ||||||||||||||||||||||
| Less: Interest expense | (36) | (46) | (113) | (158) | ||||||||||||||||||||||
| Add: Interest income | 3 | 5 | 10 | 18 | ||||||||||||||||||||||
| Less: Net income attributable to non-controlling interests | (3) | (2) | (8) | (6) | ||||||||||||||||||||||
| Adjusted net income from continuing operations | $ | 283 | $ | 245 | $ | 805 | $ | 719 | ||||||||||||||||||
(1)Material restructuring programs includes restructuring and related expenses for the 2018 Rigid Packaging Restructuring Plan and the 2019 Bemis Integration Plan for the three and nine months ended March 31, 2021 and 2020. Refer to Note 4, "Restructuring Plans," for more information about the Company's restructuring plans.
(2)Material acquisition costs and other includes Bemis transaction related costs and integration costs not qualifying as exit costs for the three and nine months ended March 31, 2021 and 2020. Material acquisition costs and other for the nine months ended March 31, 2020 includes $58 million amortization of Bemis acquisition related inventory fair value step-up and $58 million of Bemis transaction related costs and integration costs not qualifying as exit costs.
(3)Amortization of acquired intangible assets from business combinations includes amortization expenses related to all acquired intangible assets from acquisitions impacting the periods presented, including $26 million of sales backlog amortization for the nine months ended March 31, 2020 from the Bemis acquisition.
(4)Impact of hyperinflation includes the adverse impact of highly inflationary accounting for subsidiaries in Argentina where the functional currency was the Argentine Peso.
40
(5)Net gain on disposals includes the gain realized upon the disposal of AMVIG and the loss upon disposal of other non-core businesses not part of material restructuring programs. Refer to Note 17, "Disposals" for more information about the Company's disposals.
(6)Net tax impact on items (1) through (5) above.
41
Reconciliation of Net Debt
A reconciliation of total debt to net debt at March 31, 2021 and June 30, 2020 is as follows:
| ($ in millions) | March 31, 2021 | June 30, 2020 | ||||||||||||
| Current portion of long-term debt | $ | 13 | $ | 11 | ||||||||||
| Short-term debt | 94 | 195 | ||||||||||||
| Long-term debt, less current portion | 6,497 | 6,028 | ||||||||||||
| Total debt | 6,604 | 6,235 | ||||||||||||
| Less cash and cash equivalents | 690 | 743 | ||||||||||||
| Net debt | $ | 5,914 | $ | 5,492 | ||||||||||
Supplemental Guarantor Information
Amcor plc, along with certain wholly owned subsidiary guarantors, guarantee the following senior notes issued by the wholly owned subsidiaries, Amcor Finance (USA), Amcor Flexibles North America, Inc. (formerly known as Bemis Company, Inc.) and Amcor UK Finance plc.
•4.500% Guaranteed Senior Notes due 2021 of Amcor Flexibles North America, Inc.
•3.100% Guaranteed Senior Notes due 2026 of Amcor Flexibles North America, Inc.
•2.630% Guaranteed Senior Notes due 2030 of Amcor Flexibles North America, Inc.
•3.625% Guaranteed Senior Notes due 2026 of Amcor Finance (USA), Inc.
•4.500% Guaranteed Senior Notes due 2028 of Amcor Finance (USA), Inc.
•1.125% Guaranteed Senior Notes due 2027 of Amcor UK Finance plc
The three notes issued by Amcor Flexibles North America, Inc. are guaranteed by its parent entity Amcor plc and the subsidiary guarantors Amcor Pty Ltd (formerly known as Amcor Limited), Amcor Finance (USA), Inc. and Amcor UK Finance plc. The two notes issued by Amcor Finance (USA), Inc. are guaranteed by its parent entity Amcor plc and the subsidiary guarantors Amcor Pty Ltd, Amcor Flexibles North America, Inc. and Amcor UK Finance plc. The note issued by Amcor UK Finance plc is guaranteed by its parent entity, Amcor plc, and the subsidiary guarantors Amcor Pty Ltd, Amcor Flexibles North America, Inc. and Amcor Finance (USA), Inc.
All guarantors fully, unconditionally and irrevocably guarantee, on a joint and several basis, to each holder of the notes the due and punctual payment of the principal of, and any premium and interest on, such note and all other amounts payable, when and as the same shall become due and payable, whether at stated maturity, by declaration of acceleration, call for redemption or otherwise, in accordance with the terms of the notes and related indenture. The obligations of the applicable guarantors under their guarantees will be limited as necessary to recognize certain defenses generally available to guarantors (including those that relate to fraudulent conveyance or transfer, voidable preference, financial assistance, corporate purpose or similar laws) under applicable law. The guarantees will be unsecured and unsubordinated obligations of the guarantors and will rank equally with all existing and future unsecured and unsubordinated debt of each guarantor. None of our other subsidiaries guarantee such notes. The issuers and guarantors conduct large parts of their operations through other subsidiaries of Amcor plc.
Amcor Flexibles North America, Inc. is incorporated in Missouri in the United States, Amcor Finance (USA) Inc. is incorporated in Delaware in the United States, Amcor UK Finance plc is incorporated in England and Wales, United Kingdom and the guarantors are incorporated under the laws of Jersey, Australia, the United States, and England and Wales and, therefore, insolvency proceedings with respect to the issuers and guarantors could proceed under, and be governed by, among others, Jersey, Australian, United States or English insolvency law, as the case may be, if either issuer or any guarantor defaults on its obligations under the applicable Notes or Guarantees, respectively.
Set forth below is the summarized financial information of the combined Obligor Group made up of Amcor plc (as parent guarantor), Amcor Flexibles North America, Inc., Amcor Finance (USA), Inc. and Amcor UK Finance plc (as subsidiary issuers of the notes and guarantors of each other’s notes) and Amcor Pty Ltd (as the remaining subsidiary guarantor).
42
Basis of Preparation
Amcor has voluntarily adopted amendments to the financial disclosure requirements for guarantors and issuers of guaranteed securities registered or being registered as issued by the SEC [Release No. 33-10762; 34-88307; File No. S7-19-18] in March 2020. The following summarized financial information is presented for the parent, issuer, and guarantor subsidiaries ("Obligor Group") on a combined basis after elimination of intercompany transactions between entities in the combined group and amounts related to investments in any subsidiary that is a non-guarantor.
This information is not intended to present the financial position or results of operations of the combined group of companies in accordance with U.S. GAAP.
Statement of Income for Obligor Group
| ($ in millions) | Nine Months Ended March 31, 2021 | |||||||
| Net sales - external | $ | 698 | ||||||
| Net sales - to subsidiaries outside the Obligor Group | 4 | |||||||
| Total net sales | 702 | |||||||
| Gross profit | 136 | |||||||
Income from continuing operations (1) | 665 | |||||||
| Income (loss) from discontinued operations, net of tax | — | |||||||
| Net income | $ | 665 | ||||||
| Net (income) loss attributable to non-controlling interests | — | |||||||
| Net income attributable to Obligor Group | $ | 665 | ||||||
(1)Includes $724 million net income from subsidiaries outside the Obligor Group mainly made up of intercompany dividend and interest income.
Balance Sheets for Obligor Group
| (in millions) | March 31, 2021 | June 30, 2020 | ||||||||||||
| Assets | ||||||||||||||
| Current assets - external | $ | 512 | $ | 899 | ||||||||||
| Current assets - due from subsidiaries outside the Obligor Group | 68 | 136 | ||||||||||||
| Total current assets | 580 | 1,035 | ||||||||||||
| Non-current assets - external | 362 | 1,002 | ||||||||||||
| Non-current assets - due from subsidiaries outside the Obligor Group | 13,039 | 12,405 | ||||||||||||
| Total non-current assets | 13,401 | 13,407 | ||||||||||||
| Total assets | $ | 13,981 | $ | 14,442 | ||||||||||
| Liabilities | ||||||||||||||
| Current liabilities - external | $ | 1,092 | $ | 1,647 | ||||||||||
| Current liabilities - due from subsidiaries outside the Obligor Group | 14 | 36 | ||||||||||||
| Total current liabilities | 1,106 | 1,683 | ||||||||||||
| Non-current liabilities - external | 6,928 | 6,074 | ||||||||||||
| Non-current liabilities - due from subsidiaries outside the Obligor Group | 11,205 | 11,201 | ||||||||||||
| Total non-current liabilities | 18,133 | 17,275 | ||||||||||||
| Total liabilities | $ | 19,239 | $ | 18,958 | ||||||||||
43
New Accounting Pronouncements
Refer to Note 2, "New Accounting Guidance," in "Item 1. Financial Statements - Notes to Condensed Consolidated Financial Statements."
Critical Accounting Estimates and Judgments
Our discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Our estimates and judgments are based on historical experience and on various other factors that are believed to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions. These critical accounting estimates are discussed in detail in “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Estimates and Judgments” in our Annual Report on Form 10-K for the year ended June 30, 2020.
44
Liquidity and Capital Resources
We finance our business primarily through cash flows provided by operating activities, borrowings from banks and proceeds from issuances of debt and equity. We periodically review our capital structure and liquidity position in light of market conditions, expected future cash flows, potential funding requirements for debt refinancing, capital expenditures and acquisitions, the cost of capital, sensitivity analyses reflecting downside scenarios, the impact on our financial metrics and credit ratings, and our ease of access to funding sources.
During the nine months ended March 31, 2021, the company repaid €100 million Euro Private Placement Notes on September 1, 2020.
Despite the existing market uncertainties and volatilities stemming from the COVID-19 pandemic, based on our current and expected cash flow from operating activities and available cash, we believe our cash flows provided by operating activities, together with borrowings available under our credit facilities and access to the commercial paper market back stopped by our bank facilities, will continue to provide sufficient liquidity to fund our operations, capital expenditures and other commitments, including dividends and purchases of our ordinary shares and CHESS Depositary Instruments under authorized share repurchase programs, into the foreseeable future.
Overview
| Nine Months Ended March 31, | ||||||||||||||||||||
| ($ in millions) | 2021 | 2020 | Change | |||||||||||||||||
| Net cash provided by operating activities | $ | 617 | $ | 470 | $ | 147 | ||||||||||||||
| Net cash (used in) provided by investing activities | (115) | 117 | (232) | |||||||||||||||||
| Net cash used in financing activities | (601) | (590) | (11) | |||||||||||||||||
Cash Flow Overview
Net Cash Provided by Operating Activities
Net cash provided by operating activities increased by $147 million, or 31%, to $617 million for the nine months ended March 31, 2021, from $470 million for the nine months ended March 31, 2020. The increase was mainly driven by inflows from increased net income, partially offset by working capital outflows.
Net Cash (Used in) Provided by Investing Activities
Net cash flow from investing activities decreased by $232 million, or 198%, to $115 million outflow for the nine months ended March 31, 2021, from a $117 million inflow for the nine months ended March 31, 2020. This decrease was primarily due to higher disposal proceeds in the prior period mainly from the EC Remedy related to the Bemis acquisition.
Net Cash Used in Financing Activities
Net cash outflow from financing activities increased by $11 million to $601 million for the nine months ended March 31, 2021, from a $590 million outflow for the nine months ended March 31, 2020. This increase was primarily due to higher cash net debt drawdowns in the prior period, partially offset by lower share buy back payments in the current period.
Net Debt
We borrow from financial institutions and debt investors in the form of bank overdrafts, bank loans, corporate bonds, unsecured notes and commercial paper. We have a mixture of fixed and floating interest rates and use interest rate swaps to provide further flexibility in managing the interest cost of borrowings.
Short-term debt consists of bank debt with a duration of less than 12 months and bank overdrafts which are classified as current due to the short-term nature of the borrowings, except where we have the ability and intent to refinance and as such extend the debt beyond 12 months. The current portion of the long-term debt, except where we have the ability and intent to refinance, consists of debt amounts repayable within a year after the balance sheet date.
45
Our primary bank debt facilities and notes are unsecured and subject to negative pledge arrangements limiting the amount of secured indebtedness we can incur to a range between 7.5% to 15.0% of our total tangible assets, subject to some exceptions and variations by facility. In addition, the bank debt facilities and U.S. private placement debt require us to comply with certain financial covenants, including leverage and interest coverage ratios. The negative pledge arrangements and the financial covenants are defined in the related debt agreements. As of March 31, 2021, we were in compliance with all applicable covenants under our bank debt facilities and U.S. private placement debt.
Our net debt as of March 31, 2021 and June 30, 2020 was $5.9 billion and $5.5 billion, respectively.
Available Financing
As of March 31, 2021, we had undrawn credit facilities available in the amount of $1.2 billion. Our senior facilities are available to fund working capital, growth capital expenditures and refinancing obligations and are provided to us by four separate bank syndicates.
During the quarter ending March 31, 2021, we extended $3.75 billion in aggregate amount of our 3-, 4-, and 5-year revolving credit facilities via a one-year extension option to April 2023, 2024, and 2025, respectively. In addition to extending maturities, we also amended credit terms of the revolving facilities, which among other changes, modified the debt covenant basis. The amendments removed the financial covenant requiring compliance with a minimum net interest expense coverage ratio, increased maximum permitted leverage ratio and permit further increases at our election after we would consummate certain qualified transactions.
As of March 31, 2021, the revolving senior bank debt facilities had an aggregate limit of $4.1 billion, of which $2.9 billion had been drawn (inclusive of amounts drawn under commercial paper programs reducing the overall balance of available senior facilities). Our senior facilities mature between fiscal years 2022 and 2025.
Dividend Payments
We declared and paid a $0.1150 cash dividend per ordinary share during the first fiscal quarter which ended September 30, 2020, a $0.1175 cash dividend per ordinary share during the second fiscal quarter which ended December 31, 2020, and a $0.1175 cash dividend per ordinary share during the third fiscal quarter which ended March 31, 2021.
Credit Rating
Our capital structure and financial practices have earned us investment grade credit ratings from two internationally recognized credit rating agencies. These credit ratings are important to our ability to issue debt at favorable rates of interest, for various tenors and from a diverse range of markets that are highly liquid, including European and U.S. debt capital markets and from global financial institutions.
Share Repurchases
On November 5, 2020, the Company's Board of Directors approved a $150 million buyback of ordinary shares and Chess Depositary Instruments ("CDIs"). Additionally, on February 2, 2021, the Company's Board of Directors approved an additional $200 million buyback of ordinary shares and CDIs in the next twelve months. During the nine months ended March 31, 2021, we repurchased approximately $308 million of ordinary shares and CDIs in the aggregate, including transaction costs, or 26.7 million shares. The shares repurchased as part of the program were canceled upon repurchase. During the nine months ended March 31, 2020, we repurchased approximately $478 million of ordinary shares and CDIs in the aggregate, which value includes transaction costs, or 51.5 million shares.
We had cash outflows of zero and $11 million for the purchase of our shares in the open market during the nine months ended March 31, 2021 and 2020, respectively, as treasury shares to satisfy the vesting and exercises of share-based compensation awards. As of March 31, 2021, and June 30, 2020, we held treasury shares at cost of $40 million and $67 million, representing 4.0 million and 6.7 million shares, respectively.
46
Item 3. Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes in our market risk during the three and nine months ended March 31, 2021. For additional information, refer to Note 7, "Fair Value Measurements," and Note 8, "Derivative Instruments," to the notes to our unaudited condensed consolidated financial statements and to "Item 7A. - Quantitative and Qualitative Disclosures About Market Risk" of our Annual Report on Form 10-K for the year ended June 30, 2020.
47
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2021. The term "disclosure controls and procedures," as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including its principal executive and financial officers, as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation conducted, our Chief Executive Officer and Chief Financial Officer have concluded that the Company's disclosure controls and procedures were not effective as of March 31, 2021, due to the existence of a material weakness in our internal control over financial reporting that was identified in our prospectus filed with the SEC on March 25, 2019 and is still being remediated, as described below.
Material Weakness in Internal Control Over Financial Reporting
A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement in our annual or interim financial statements will not be prevented or detected on a timely basis.
As previously disclosed, we identified a material weakness arising from deficiencies in the design and operating effectiveness of internal controls over the period end reporting process. Specifically, we did not design and maintain effective controls to verify that conflicting duties were appropriately segregated within key IT systems used in the preparation and reporting of financial information. This control deficiency did not result in a misstatement of our consolidated financial statements. However, the control deficiency could have resulted in misstatements of our interim or annual consolidated financial statements and disclosures that may have not been prevented or detected on a timely basis.
Remediation Efforts to Address Material Weakness
We are in the process of remediating the material weakness described above and have (i) developed and implemented additional controls and procedures to reduce the number of segregation of duties conflicts within key IT systems, which includes the implementation of new security roles and the automation of segregation of duties monitoring where practical, (ii) designed and implemented additional compensating controls where necessary and (iii) developed training on segregation of duties. Given we operate many key ERP systems globally, this effort targeted the largest of these key systems in fiscal 2020 and has been expanded in fiscal 2021 to cover our remaining key systems. These enhanced processes, including the implementation of new mitigating controls, will effectively remediate the material weakness, but the material weakness will not be considered remediated until the revised controls operate for a sufficient period of time and we have concluded, through testing to be completed in the fourth fiscal quarter of 2021, that they are designed and operating effectively. We continue to expect that this material weakness will be fully remediated by the end of fiscal 2021. However, there is no assurance that this material weakness will be fully remediated by the end of fiscal 2021.
a)Changes in Internal Control Over Financial Reporting
Except as described above, there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the third fiscal quarter of 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
48
Part II - Other Information
Item 1. Legal Proceedings
The material set forth in Note 16, "Contingencies and Legal Proceedings," in "Item 1. Financial Statements - Notes to Condensed Consolidated Financial Statements" is incorporated herein by reference.
Item 1A. Risk Factors
There have been no material changes from the risk factors contained in "Item 1A. - Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended June 30, 2020.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Share Repurchases
Share repurchase activity during the three months ended March 31, 2021 was as follows (in USD millions, except number of shares, which are reflected in thousands, and per share amounts, which are expressed in USD):
| Period | Total Number of Shares Purchased | Average Price Paid Per Share (2) | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Approximate Dollar Value of Shares That May Yet Be Purchased Under the Programs (1) | ||||||||||||||||||||||
| January 1 - 31, 2021 | — | $ | — | — | $ | 75 | ||||||||||||||||||||
| February 1 - 28, 2021 | 8,689 | 11.41 | 8,689 | 176 | ||||||||||||||||||||||
| March 1 - 31, 2021 | 11,496 | 11.57 | 11,496 | 43 | ||||||||||||||||||||||
| Total | 20,185 | $ | 11.50 | 20,185 | ||||||||||||||||||||||
(1) On November 5, 2020, our Board of Directors approved a buyback program of $150 million of ordinary shares and CHESS Depositary Instruments ("CDIs") during the following twelve months. In addition, on February 2, 2021, our Board of Directors approved an additional $200 million buyback of ordinary shares and CDIs during the following twelve months. The timing, volume and nature of share repurchases may be amended, suspended or discontinued at any time.
(2) Average price paid per shares excludes costs associated with the repurchase.
Item 3. Defaults Upon Senior Securities
Not applicable.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
Not applicable.
49
Item 6. Exhibits
The documents in the accompanying Exhibits Index are filed, furnished or incorporated by reference as part of this Quarterly Report on Form 10-Q, and such Exhibits Index is incorporated herein by reference.
| Exhibit | Description | ||||||||||||||||
| 22 | |||||||||||||||||
| 31 | .1 | ||||||||||||||||
| 31 | .2 | ||||||||||||||||
| 32 | |||||||||||||||||
| 101 | .INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document. | |||||||||||||||
| 101 | .SCH | Inline XBRL Taxonomy Extension Schema Document. | |||||||||||||||
| 101 | .CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | |||||||||||||||
| 101 | .DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | |||||||||||||||
| 101 | .LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | |||||||||||||||
| 101 | .PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | |||||||||||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | ||||||||||||||||
50
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| AMCOR PLC | |||||||||||
| Date | May 6, 2021 | By | /s/ Michael Casamento | ||||||||
| Michael Casamento, Executive Vice President and Chief Financial Officer (Principal Financial Officer) | |||||||||||
| Date | May 6, 2021 | By | /s/ Julie Sorrells | ||||||||
| Julie Sorrells, Vice President and Corporate Controller (Principal Accounting Officer) | |||||||||||
51
EXHIBIT 22
LIST OF GUARANTORS AND SUBSIDIARY ISSUERS OF GUARANTEED SECURITIES AS OF MARCH 31, 2021
The following is a list of guarantors of the 4.500% Senior Notes due 2021, 3.100% Senior Notes due 2026 and 2.630% Senior Notes due 2030 issued by Amcor Flexibles North America, Inc. (formerly known as Bemis Company, Inc.), the 3.625% Senior Notes due 2026 and 4.500% Senior Notes due 2028 issued by Amcor Finance (U.S.A.) Inc. All of the issuers listed above are wholly owned subsidiaries of Amcor plc.
| Name of Guarantor | Jurisdiction of Incorporation | |||||||
| Amcor plc | Jersey | |||||||
| Amcor Flexibles North America, Inc. (1) | United States of America | |||||||
| Amcor Finance (U.S.A.) Inc. (1) | United States of America | |||||||
| Amcor Pty Ltd | Australia | |||||||
| Amcor UK Finance plc (1) | United Kingdom | |||||||
(1)Amcor Flexibles North America Inc., Amcor Finance (U.S.A.) Inc. and Amcor UK Finance plc guarantee each other’s notes.
The following is a list of guarantors of the 1.125% Senior Notes due 2027 issued by Amcor UK Finance plc, a wholly owned subsidiary of Amcor plc.
| Name of Guarantor | Jurisdiction of Incorporation | |||||||
| Amcor plc | Jersey | |||||||
| Amcor Flexibles North America, Inc. | United States of America | |||||||
| Amcor Finance (U.S.A.) Inc. | United States of America | |||||||
| Amcor Pty Ltd | Australia | |||||||
EXHIBIT 31.1
RULE 13a-14(a)/15d-14(a) CERTIFICATION OF CEO
I, Ronald Delia, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Amcor plc;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
| Date | May 6, 2021 | /s/ Ronald Delia | |||||||||
| Ronald Delia, Managing Director and Chief Executive Officer | |||||||||||
EXHIBIT 31.2
RULE 13a-14(a)/15d-14(a) CERTIFICATION OF CFO
I, Michael Casamento, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Amcor plc;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
| Date | May 6, 2021 | /s/ Michael Casamento | |||||||||
| Michael Casamento, Executive Vice President and Chief Financial Officer (Principal Financial Officer) | |||||||||||
EXHIBIT 32
SECTION 1350 CERTIFICATIONS OF CEO AND CFO
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned certifies that the Quarterly Report on Form 10-Q of Amcor plc for the quarter ended March 31, 2021 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Amcor plc.
| /s/ Ronald Delia | /s/ Michael Casamento | ||||||||||
| Ronald Delia, Managing Director and Chief Executive Officer | Michael Casamento, Executive Vice President and Chief Financial Officer (Principal Financial Officer) | ||||||||||
| Date | May 6, 2021 | Date | May 6, 2021 | ||||||||